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ABSTRACT 
The decomposition of steroid and other organic hydroperoxides 
by microsomes from rat liver and bovine adrenal cortex has been examined 
using TMPD as an electron donor. A comparison of the hydroperoxide 
specificity of microsomal peroxidase revealed the 17a-hydroperoxide 
derivatives of progesterone and pregnenolone to be very effective sub-
strates. Treatment of rats with phenobarbital or 3-methylcholanthrene 
enhanced the specific activity of microsomal peroxidase and the 
cytochrome P-450 content to a similar extent. Microsomal "P-450 par-
ticles" devoid of cytochrome b showed the same peroxidase activity 
-5 
per mole of P-450 as did original microsomes. Further evidence for 
P-450 being a microsomal peroxidase was the inhibition of peroxidase 
activity by type I, type II, and modified type II compounds and by 
reagents converting P-450 to P~420. 
The rate of NADPH or NADH oxidation by microsomal fractions 
was markedly enhanced by the hydroperoxides. Evidence for the involve-
ment of NADPH-cytochrome ~ reductase in NADPH-peroxidase activity 
indluded a similar K for NADPH; inhibition by £-mercuribenzoate 
m 
with partial protection by NADPH; inh~&ition by NADP+; and inactivation 
by antiserum to the flavoenzyme. Evidence of a role for NADH-cytochrome 
b 5 reductase in NADH-peroxidase activity included a similar Km for NADH; 
inhibition by £-mercuribenzoate with partial protection by NADH; 
and inactivation by antibody to the flavoprotein. 
Evidence for the involvement of P-450 in the NAD(P)H-peroxidase 
(iii) 
reaction included inhibition by type I, type II, and modified type II 
compounds; inhibition by reagents converting P-450 to P-420; and marked 
stimulation by in vivo phenobarbital treatment. The NADPH- and NADH-
reduced forms of P-450 were oxidized very rapidly by cumene hydroperoxide 
under a CO atmosphere. Incubation of the hydroperoxides with microsomal 
fractions gave rise to the corresponding hydroxy derivatives as the 
major products. 
Mechanisms for the P-450-dependent reduction of hydroperoxides 
are proposed and the role of hydroperoxides as possible intermediates in 
biological hydroxylation reactions discussed. 
NADPH 
NADP+ 
NADH 
NAD+ 
GSH 
TMPD 
gc 
ms 
tlc 
EDTA 
P-450 
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ABBREVIATIONS 
- reduced nicotinamide adenine dinucleotide phosphate 
- nicotinamide adenine dinucleotide phosphate 
reduced nicotinamide adenine dinucleotide 
nicotinamide a4enine dinucleotide 
reduced glutathione 
N,N,N' ,N'-tetramethyl-£-phenylenediamine 
gas chromatography 
- mass spectrometry 
thin layer chromatography 
- ethylenediaminetetraacetate 
cytochrome P-450 
(v) 
Systematic nomenclature for compounds given trivial names in the 
text include: 
pregn-4-ene-3,20-dione progesterone 
3S-hydroxypregn-5-en-20-one pregnenolone 
17a,21-dihydroxypregn-4-ene-3,20-dione 17a,21-dihydroxyprogesterone 
17a-hydroxypregn-4-ene-3,20-dione 17a-hydroxyprogesterone 
3S,l7a-dihydroxypregn-5-en-20-one 17a-hydroxypregnenolone 
androst-4-ene-3,17-dione androstenedione 
3S-hydroxyandrost-5-en-17-one dehydroepiandrosterone 
3S-hydroxy-5a-pregnan-20-one allopregnanolone 
17S-hydroxyandrost-4-en-3-one --- testosterone 
cholest-5-en-3S-ol cholesterol 
4,4,14a-trimethyl-5a-cholesta-8,24-dien-3S-ol lanosterol 
2-phenyl-2-hydroperoxypropane cumene hydroperoxide 
£-ethoxyacetanilide --- phenacetin 
o-biphenylenemethane fluorene 
1,2,3,4-tetrahydronaphthalene tetralin 
1,2,3,4-tetrahydro-2-naphthol tetralol 
(vi) 
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INTRODUCTION 
Enzymes that incorporate one atom of molecular oxygen into 
substrate while concomitantly reducing the other atom to water are termed 
mixed-function oxidases or mono-oxygenases (1). The stoichiometry of the 
reaction may be represented as 
RH + NAD(P)H + H+ + 0 2 ~ ROH + NAD(P)+ + H20 
where RH is the substrate and NAD(P)H the electron donor. The reaction 
results in the oxidation of one mole of NAD(P)H and consumption of one 
mole of oxygen during the formation of one mole of hydroxylated product. 
The importance of mixed-function oxidases in biological systems is evident 
from the wide diversity of substances that are metabolized by these 
enzymes (2-5). 
I. Mixed-function oxidase reactions in liver microsomes 
1. Hydroxylation of drugs and foreign compounds 
Studies in vitro have revealed that the endoplasmic reticulum of 
liver is the major site for the metabolism of a large variety of drugs, 
carcinogens, and other foreign compounds by nonspecific enzymes. These 
oxidative enzymes fit the category of mixed-function oxidases and require 
the participation of NADPH and molecular oxygen. In some instances, NADH 
may substitute for NADPH but the rate of the reaction is markedly reduced. 
The versatility of these enzyme systems is virtually unique in 
biochemistry as they catalyze such diverse reactions as the oxidation of 
aliphatic and aromatic hydrocarbons, the deamination of various substances, 
the dealkylation of secondary and tertiary amines, the oxidative cleavage 
of ethers, the sulfoxidation of thio-ethers, and the epoxidation of 
aromatic hydrocarbons and alkenes (2,3). 
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Shortly after the discovery of these reactions, Brodie and 
colleagues (4) pointed out that many of these reactions could be visualized 
as hydroxylation reactions in which unstable hydroxylated intermediates 
were formed. These investigators also suggested that NADPH participates 
in these reactions by reducing a component in liver microsomes that reacts 
with oxygen to form an "active oxygen" complex which in turn hydroxylates 
the various substrates. The component reduced by NADPH was found to be a 
carbon monoxide-binding pigment named cytochrome P-450. It was later 
established that the flavoenzyme NADPH-cytochrome ~reductase (EC 1.6.2.3) 
mediates the reduction of cytochrome P-450 by NADPH (3). 
2. Hyd~oxylation of physiological substrates 
A large number of lipid-soluble drugs and other foreign compounds 
are known to undergo hydroxylation in liver microsomes in the presence of 
NADPH and oxygen. However, the hepatic microsomal NADPH-dependent enzymes 
metabolize not only drugs but also a host of normal body substrates which 
include steroids such as testosterone, progesterone, 176-estradiol, deoxy-
corticosterone, corticosterone, and androstenedione; fatty acids; tyramine 
and other amines; thyroxin; anthranilic acid; and various indoles such as 
tryptamine and indoleacetic acid. Similarly, the biosynthesis of cholesterol 
requires the participation of NADPH-dependent enzymes in liver microsomes (5) 
as does the conversion of cholesterol to bile acids (6). Various steroid 
substrates can be hydroxylated by the liver microsomal enzyme system at the 
26, 6S, 7CJ., 76, 12CJ., and 16CJ. positions (5-7). 
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The similarities between drug and steroid hydroxylases in liver 
microsomes led investigators to suspect that drugs and steroids are sub-
strates for the same hydroxylating enzymes. This concept was strengthened 
by the finding that steroid hormones could act as competitive inhibitors 
of the drug-metabolizing enzymes (5). The inhibitory effect of carbon 
monoxide on liver microsomal steroid hydroxylations suggested that cyto-
chrome P-450 was involved in these reactions. Further evidence for the 
involvement of the hemoprotein in steroid hydroxylation came from the studies 
of Conney and coworkers (7) who demonstrated that the inhibitory effect of 
carbon monoxide on the 68-, 7a-, and 16a-hydroxylation of testosterone by 
liver microsomes is prevented by monochromatic light at 450 nm. In 
addition, the low Michaelis-Menten constants found for the hydroxylation of 
testosterone, progesterone, and 178-estradiol by liver microsomes provided 
additional support for the concept that steroid hormones are normal physio-
logical substrates for the oxidative drug-metabolizing enzymes (8). 
II. Mixed-function oxidase reactions in non-hepatic tissues 
1. Hydroxylation of drugs and carcinogens 
Although oxidative drug-metabolizing enzymes are localized primar-
ily in liver microsomes, low levels of these enzymes are also present in 
various non-hepatic tissues (5). For example, Wattenberg and Leong (9) 
found NADPH-dependent 3,4-benzpyrene hydroxylase activity in the kidney, 
adrenal, and small intestine of normal rats. Benzpyrene and 3-methylchol-
anthrene hydroxylase activity has also been detected in the lung, thyroid, 
testis, placenta, skin, and leukocyte (5, 10). Ichikawa and colleagues (11) 
observed the hydroxylation of aniline, aminopyrine, and ~-nitroanisole with 
microsomes of lung and kidney. 
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2. Hydroxylation of steroids 
The endocrine glands are the main site for the biosynthesis of the 
steroid hormones from cholesterol. In the adrenal, hydroxylases for the 
following positions of the steroid molecule have been partially purified: 
2a , 6a, 66, 11 6 , 17a, 18, 19, 20, 21 and 22. The 2a-, 17a, and 21-hydroxy-
lases are located in the microsomes whereas the remaining enzymes are 
localized in the mitochondria (12). In the ovary, testis and placenta, the 
17a-hydroxylases appear to be associated with the endoplasmic reticulum (13, 
14). A mixed-function oxidase enzyme system that utilizes NADPH and molecular 
oxygen to catalyze the side-chain cleavage of cholesterol to pregnenolone 
appears to be an integral part of the mitochondrial structure of steroid-
producing organs (14-16). 
III. Cytochrome P~450 and its role in hydroxylation reactions 
1. Activities catalyzed by cytochrome P-450~ependent enzyme systems 
Cytochrome P-450 is distributed in the microsomes of a large variety 
of tissues and in the microsomes and mitochondria of various steroid-producing 
organs (11-18). Some of the well-known activities that are catalyzed by the 
cytochrome P-450-dependent enzyme systems in mammalian tissues are outlined 
in Table 1. All the reactions require the presence of NADPH and oxygen. 
2. The raZe of NADPH-cytochrome c reductase in cytochrome P-450-cataZyzed 
hydroxylation reactions 
Cytochrome P-450 is the terminal oxidase which catalyzes the 
hydroxylation of a large number of drugs, steroids, carcinogens, alkanes, and 
fatty acids in liver microsomes (5, 22) and the hydroxylation of steroids in 
various steroidogenic organs (12-16). In these reactions, the necessary 
reducing equivalents for the reduction of cytochrome P-450 are supplied by 
NADPH via an electron transport system which includes the flavoenzyme 
TABLE 1 
SOME REACTIONS CATALYZED BY CYTOCHROME P-450-DEPENDENT EN2YME SYSTEMS 
1. 
2. 
3. 
4. 
Activity 
Hydroxylation of drugs and 
foreign compounds 
w-Hydroxylation of fatty 
acids 
Oxygenation of heme 
Lanosterol biosynthesis 
5. Hydroxylation of steroids -
1) 26-hydroxylation 
2) 66-hydroxylation 
3) ]a-hydroxylation 
4) 16a-hydroxylation 
5) 116-hydroxylation 
6) 18-hyclroxylation 
7) 17a-hydroxylation 
8) 21-hydroxylation 
6. Side-chain cleavage 
Substrate(s) Source 
codeine; acetanilide; 4-methyl-
aminoantipyrine liver microsomes 
cyclohexane; hexane; octane 
benzphetamine; ethylmorphine; 
hexobarbital; aminopyrine; 
norcodeine 
3,4-benzpyrene; chlorcyclizine 
liver microsomes 
liver microsomes 
liver microsomes 
laurate; octanoate; palmitoleate liver microsomes 
laurate 
heme 
heme 
squalene 
testosterone 
testosterone; androstenedione; 
176-estradiol 
cholesterol; testosterone 
testosterone; 176-estradiol; 
pregnenolone 
deoxycorticosterone 
corticosterone 
progesterone 
17a-hydroxyprogesterone 
cholesterol 
kidney cortex 
microsomes 
liver microsomes 
spleen microsomes 
liver microsomes 
liver microsomes 
liver microsomes 
liver microsomes 
liver microsomes 
adrenal cortex 
mitochondria 
adrenal cortex 
mitochondria 
adrenal cortex 
microsomes 
testis microsomes 
adrenal cortex 
microsomes 
mitochondria from 
adrenal cortex, 
testis, ovary, 
placenta 
rat 
rat, rabbit 
rat, rabbit 
rat 
rat, rabbit 
rat 
rat, pig 
rat, pig 
rat 
rat 
rat 
rat 
rat 
steer 
steer 
steer 
rat 
steer 
steer, rat 
References 
(19' 20) 
(21' 22) 
(21) 
(23) 
(21, 22) 
(24) 
(25) 
(25) 
(26) 
(26) 
(7' 26) 
(6' 7) 
(26' 27) 
(12) 
(12) 
(12) 
(13) 
(12) 
(14-16) 
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NADPH-cytochrome ~ reductase as the acceptor of electrons from NADPH. 
The reduction of cytochrome P - 450 by NADPH is normally measured 
at 450 nm under a carbon monoxide atmosphere in the absence of oxygen since 
the reduced hemoprotein in the membrane-bound state is highly autoxidizable. 
Carbon monoxide binds only the reduced form of cytochrome P- 450. However, 
actual rates of cytochrome P-450 reduction are difficult to obtain since 
the initial phase of the reaction is very rapid. Therefore, exogenous 
cytochrome ~ is usually employed in the assay medium as the in vitro 
acceptor of electrons from NADPH. 
The Km for NADPH during aminopyrine demethylation in rabbit liver 
microsomes was found by Cohen and Estabrook (28) to be approximately 1 ~M. 
This value correlates very well with the Km values reported for NADPH 
(1-4 ~M) by other investigators for purified NADPH-cytochrome c reductase 
(11, 29, 30). 
The activity of microsomal NADPH-cytochrome ~ reductase is 
+ inhibited by NADP , by low concentrations of sulfhydryl reagents, and by 
antibody prepared against the flavoprotein (29-31). These compounds are 
known to inhibit to a similar extent various microsomal hydroxylation react-
ions (28, 32, 33). 
3. Type I~ Type II~ and modified Type II -spectral changes 
Interaction of various compounds with oxidized cytochrome P-450 
in liver microsomes is known to cause three types of alterations of the 
difference spectrum termed type I, type II, and modified type II spectral 
changes (34, 35). The type I spectral change is characterized by the format-
ion of a peak at about 390 nm and a trough at about 420 nm in the difference 
spectrum. This type of spectral change was reported to be caused by a 
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modification of an existing ligand of the P-450 heme. A large number of 
compounds ranging from drugs and carcinogens to fatty acids and steroids 
are known to cause the type I spectral change and most of these substances 
appear to be substrates for the cytochrome P-450-dependent enzyme system 
(35). 
Compounds causing the type II spectral change produce an 
absorption maximum at 425-435 nm and an absorption minimum at 390-395 nm 
in the difference spectrum. The type II ligands are believed to bind 
directly to the heme iron of oxidized cytochrome P-450 to form a hemichrome. 
At present, only a few type II compounds are known to act as substrates for 
cytochrome P-450 (35). 
A third class of compounds cause spectral changes of the modified 
type II category. This spectral change was suggested as being due to the 
displacement of some pre-existing substrate, bound in vivo, from cytochrome 
P-450. Interaction of the hemoprotein with modified type II compounds 
appears to be at a site different from the type I-binding site and distinct 
from the type II (heme iron) site (35). 
The type I, type II, and modified type II compounds are known to 
act as effective inhibitors of various cytochrome P-450-dependent hydroxy-
lation reactions (11, 21, 36). 
4. Conversion of cytochrome P-450 to cytochrome P-420 
Cytochrome P-450 in liver microsomes acts as a site of both oxygen 
and substrate activation for hydroxylations of lipid-soluble compounds. The 
reactive area of cytochrome P-450, i.e. the vicinity of the heme, appears to 
be embedded in a highly hydrophobic portion of P-450 protein or phospholipid 
of the microsomal membrane and this hydrophobic environment seems to be 
essential for substrate hydroxylation. Reagents such as proteases, sulfhydryl 
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reagents, detergents, alcohols, protein denaturants, strong oxidizing agents, 
acidic or alkaline solutions alter the hydrophobic environment of the heme and 
change the conformation of cytochrome P-450 and this process results in the 
conversion of cytochrome P-450 into a modified form called cytochrome P-420, 
termed in this manner because the carbon monoxide complex of the reduced 
hemoprotein shows an absorption maximum at 420 nm. The conversion of cyto-
chrome P-450 to cytochrome P-420 is usually accompanied by an inactivation 
of hydroxylating activity (11, 26, 37, 38). 
5. Effect of trypsin on microsomal hydroxylation activity 
Treatment of liver microsomes with low concentrations of trypsin 
(10 ~g/mg protein) is known to solubilize NADPH-cytochrome £ reductase 
completely but to leave the major portion of cytochrome P-450 still attached 
to the microsomal membrane. The trypsin treatment results in an inactivation 
of NADPH-cytochrome P-450 reductase activity parallel to the release of 
NADPH-cytochrome £ reductase from the microsomal membrane. Associated with 
these two phenomena is a concomitant inhibition of the NADPH-dependent drug 
hydroxylation activity. This concentration of trypsin has no effect on 
cytochrome P-450 as such, indicating that the inhibitions observed are not 
due to the conversion of cytochrome P-450 into its inactive P-420 form. On 
the other hand, NADPH-cytochrome £ reductase activity is not inhibited by the 
trypsin treatment and is in fact slightly enhanced. Orrenius and collabor-
ators (38) concluded that the release of NADPH-cytochrome £ reductase from 
the microsomal membrane is responsible for the decreased rate of cytochrome 
P-450 reduction by NADPH and the concomitant inhibition of drug hydroxylation 
activity. 
- 9 -
6. Cytochrome ~ and NADH in microsomal hydroxylation reactions 
In addition to the NADPH-linked electron transport pathway, 
liver microsomes contain a second electron transport system, composed 
of NADH-cytochrome b 5 reductase (EC 1.6.2.2) and cytochrome~' which 
utilizes NADH as the source of reducing equivalents. NADH is capable of 
reducing cytochrome P-450 but the electron transport components involved 
in this reaction sequence have not been identified with certainty (32, 39). 
Ichikawa and associates (11) found that purified NADPH-cytochrome c 
reductase can accept NADH as an electron donor. However, the K of NADH 
m 
(1.3 mM) for the isolated flavoenzyme was found to be about 400 times 
larger than the K of NADPH (3.2 ~M) suggesting that the flavoprotein does 
m 
not normally accept reducing equivalents from NADH. Later, Ichikawa and 
Loehr (39) discovered that cytochrome P-450 in hepatic submicrosomal 
particles devoid of cytochrome E5 could be reduced by physiological con-
centrations of NADH (10 ~M) presumably by way of the flavoenzyme NADH-
cytochrome E5 reductase. The Km of NADH for the purified flavoprotein has 
been reported to be 2.7 ~ (40). 
The process of substrate hydroxylation by cytochrome P-450-
dependent enzymes requires two reducing equivalents whereas the reduction 
of ferric cytochrome P-450 to ferrous cytochrome P-450 by NADPH is a one-
electron process. Both NADPH and NADH can reduce cytochrome E5 as well as 
cytochrome P-450 in liver microsomes. The first electron required for 
NADPH-dependent hydroxylation reactions is believed to be transferred to 
cytochrome P-450 from NADPH via the flavoenzyme NADPH-cytochrome ~ 
reductase. The pathway of the second electron transfer from NADPH to 
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cytochrome P-450 (see scheme 1) is less understood. Hildebrandt and 
Estabrook (32) suggested that reduced cytochrome ~ mediates the transfer 
of the second electron into the cytochrome P-450 system. On the other 
hand, Omura* (41) found that antibody against cytochrome b 5 does not 
inhibit the NADPH-dependent hydroxylation of either aniline or aminopyrine 
indicating that cytochrome E5 may not be involved in the microsomal 
hydroxylation mechanism. 
?. Different forms of cytochrome P-450 
Cytochrome P-450 in microsomes exists both in a free state and 
in a form bound to endogenous substrate (42-44). Spectrophotometric and 
ESR studies have demonstrated the presence in liver microsomes of at 
least three forms of oxidized cytochrome P-450: (1) the low spin form of 
the hemoprotein observed in the absence of substrate; (2) a low spin form 
of cytochrome P-450 obtained when type II substances interact with the 
hemoprotein; (3) a high spin form of the ferric hemoprotein observed in 
the presence of type I compounds (44). 
In addition to these three forms, two other species of cytochrome 
P-450 can be obtained in liver microsomes by pretreatment of animals with 
various barbiturates such as phenobarbital or with polycyclic carcinogens 
such as 3-methylcholanthrene. The phenobarbital-induced form of cytochrome 
P-450 is detectable by ESR spectroscopy in a low spin state whereas the 
3-methylcholanthrene-induced form is detected as a high spin hemoprotein. 
These two forms of cytochrome P-450 differ from each other and from normal 
P-450 in structure and function (23, 41, 44-47). A sixth species of 
cytochrome P-450 that is detectable in a low spin state and exhibits a high 
*Work cited in reference 41. 
affinity for cyanide has recently been purified from liver microsomes 
by Comai and Gaylor (48). 
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In mammals, cytochrome P-450 is present in a large variety of 
tissues -such as liver, lung, spleen, kidney, small intestine, pituitary, 
and in steroidogenic organs such as the adrenal, ovary, testis, and 
placenta. Although the hemoprotein is widely distributed, there is a con-
siderable body of evidence indicating that the cytochrome P-450's found in 
different cell types or within a single cell differ both in structure and 
in function (5, 11, 12-20, 24, 25, 41, 44). 
B. Induction of hepatic microsomal enzymes 
Although more than 200 different compounds are known to enhance 
drug metabolism by inducing liver microsomal enzymes, most studies have 
been carried out with phenobarbital and the polycyclic hydrocarbons 
3-methylcholanthrene and 3,4-benzpyrene. It has been established that 
phenobarbital and the polycyclic hydrocarbons exert their inducing effects 
by different mechanisms (5). For example, treatment of rats with pheno-
barbital accelerates almost all of the reactions catalyzed by cytochrome 
P-450 including the metabolism of ethylmorphine, hexobarbital, aminopyrine, 
acetanilide, and 3,4-benzpyrene whereas the administration of 3-methylchol-
anthrene induces relatively few enzymic reactions such as the metabolism of 
acetanilide and 3,4-benzpyrene but not that of ethylmorphine, hexobarbital, 
or aminopyrine. 
Phenobarbital-like inducers markedly enhance the activity of NADPH-
cytochrome c reductase and the concentration of cytochrome P-450, thus 
increasing the rate of reduction of the hemoprotein. Polycyclic hydrocarbons 
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such as 3-methylcholanthrene enhances the concentration of cytochrome P-450 
but not the activity of NADPH-cytochrome ~ reductase or the rate of cyto-
chrome P-450 reduction. It is thought that 3-methylcholanthrene induces 
the formation of a variant of cytochrome P-450 termed cytochrome P-448 
which exhibits different spectral properties and affinities for the various 
drug substrates than does normal cytochrome P-450 (45). 
9. Reconstitution of the cytochrome P-450-dependent hydroxylating system 
from Ziver microsomes 
Numerous attempts have been made in the past to solubilize and 
purify the liver microsomal cytochrome P-450 hydroxylating enzyme system 
in a functional state but investigators have been continually frustrated 
in thier attempts because of the ready conversion of the hemoprotein into 
its inactive P-420 form. In recent years, the liver microsomal cytochrome 
P-450 enzyme system has been solubilized and partially purified but these pre-
parations do not catalyze the hydroxylation of substrates (49-51). Recently, 
however, Lu and collaborators (21-23, 52-55) have resolved a solubilized 
preparation of the cytochrome P-450 system from liver microsomes into 
three components: cytochrome P-450, NADPH-cytochrome ~reductase, and 
a lipid fraction. The active component of the lipid fraction required 
for efficient reconstitution of hydroxylating activity was identified 
as phosphatidylcholine (56). This cytochrome P-450 preparation was 
capable of hydroxylating a large number of compounds such as drugs, 
steroids, fatty acids, and various hydrocarbons. However, it must 
be pointed out that the reductase fraction and the cytochrome P-450 
preparations were by no means pure, and therefore, more efficient 
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reconstitution of hydroxylating activity must await further purification 
of these electron transport components in a functional state. 
10. Mechanism suggested for substrate hydroxylation 
A mechanism for substrate hydroxylation which has gained 
considerable support over the years is shown in scheme 1. There are at 
least six steps which occur in the cyclic reduction and oxidation of cyto-
chrome P-450: 
i) the reversible interaction of a substrate molecule with low spin 
ferric cytochrome P-450 accompanied by the formation of a high spin 
form of the ferric-substrate complex of the hemoprotein; 
ii) the one-electron reduction of the high spin ferric-substrate complex 
of cytochrome P-450 to a ferrous-substrate complex; 
iii) the reversible interaction of oxygen with the ferrous-substrate 
complex of cytochrome P-450 to form an oxygenated or oxy-ferrous-
substrate complex; 
iv) a second one-electron reduction step required to generate an inter-
mediate which is as yet undefined. This intermediate may be a 
superoxide anion-ferrous-substrate complex of cytochrome P-450 or it 
may be a hydroperoxide derivative of the ferric-substrate complex of 
cytochrome P-450 or one of a variety of other forms; 
v) a proposed rearrangement accompanying internal oxidation and reduction 
reactions resulting in the introduction of one atom of molecular 
oxygen into the organic substrate in the form of a hydroxyl group 
concomitant with the release of the other atom of oxygen as water. 
The mechanism of transfer of one atom of oxygen to substrate with the 
Scheme 1. Mechanism for substrate (S) hydroxylation by 
cytochrome P-450 
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resultant formation of water from the remaining atom of oxygen 
remains to be elucidated; 
vi) the dissociati~n of the hydroxylated product from ferric cytochrome 
P-450 with the regeneration of a low spin form of the hemoprotein, 
thus allowing for its participation in another cycle of the reaction 
(44). 
Although not conclusive, the results obtained with the adrenal 
mitochondrial cytochrome P-450 and the liver and adrenal microsomal cyto-
chrome P-450 enzyme systems (43,44) are consistent with the mechanism 
proposed in scheme 1. 
11. StePoZ demethyZation activity in ZiveP micPosomes 
In the conversion of lanosterol (4,4,14a-trimethyl-5a-cholesta-
8,24-dien-3B-ol) to cholesterol, the methyl groups in positions 4a, 4B, 
and 14a of lanosterol are oxidized to carbon dioxide. The initial react-
ion of the oxidative demethylation process is an aerobic hydroxylation of 
each methyl group by a mixed-function oxidase enzyme requiring reduced 
pyridine nucleotide (either NADPH or NADH) as cofactor. The conversion of 
the hydroxymethyl groups to acetaldehyde derivatives followed by the form-
ation of the carboxylic acid compounds and subsequent decarboxylation produces 
carbon dioxide. The first three steps require NAD(P)H and molecular oxygen 
whereas the decarboxylation process can occur under anaerobic conditions. 
Gaylor and associates (48, 57-59) have recently proposed the 
involvement in the initial NADH-dependent hydroxylation reaction of a cyto-
chrome P-450 species that exhibits a high affinity for cyanide. However, 
the sterol demethylation reaction is unique in that the activity is insen-
sitive to inhibition by carbon monoxide and ethyl isocyanide, reagents 
which normally inhibit other microsomal cytochrome P-450-dependent 
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reactions. 
12. Hydroperoxides as possible intermediates in hydroxylation reactions 
A number of "activated oxygen" species (e.g. superoxide anions, 
hydroxyl radicals, oxenoid species, alkoxy free radicals, epoxide inter-
mediates) have been proposed as initial intermediates in the cytochrome 
P-450-catalyzed hydroxylation mechanism (44,60-62). Hydroperoxides have 
also been postulated to occur as intermediates in enzymic hydroxylation 
reactions. For example, Grant (63) studied the 118-hydroxylation of 
steroids by adrenal tissue and suggested that 118-hydroperoxide was an 
intermediate. Hydroperoxides have been identified as intermediates in 
the NADPH-dependent hydroxylation of fluorene, tetralin, and other organic 
compounds by liver microsomal preparations (64-66). Cholesterol 20~-hydro­
peroxide was found to undergo an enzymic rearrangement to 20~,21-dihydroxy­
cholesterol and 20 ,22-dihydroxycholesterol by a mitochondrial cytochrome 
P-450 preparation from adrenal cortex and the hydroperoxide has been 
proposed as an initial intermediate in pregnenolone biosynthesis (67-70). 
Boyer and associates (71) were the first to report the NADH-dependent 
reduction of alkyl hydroperoxides to alcohols by an enzyme preparation from 
Pseudomonas oleovorens. 
13. Cytochrome P-450 as a microsomal peroxidase in lipid peroxide decomposition 
The unsaturated fatty acids of intracellular membrane phospho-
lipids readily undergo peroxidation in the presence of oxygen. Many 
deleterious effects of lipid peroxides on biochemical cellular constituents 
and subcellular fractions have been reported. Hochstein and Ernster (72) 
demonstrated the inactivation by lipid peroxides of enzymes associated 
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with the membranes of the endoplasmic reticulum. 
The lipid peroxides formed in tissues are rapidly decomposed. 
O'Brien and Little (73) studied the decomposition of linoleic acid hydro-
peroxide by subcellular fractions of rat liver and found two types of 
mechanisms associated with the decomposition: (1) a reduction of the 
hydroperoxide by glutathione of the cytosol fraction catalyzed by gluta-
thione peroxidase and resulting in the formation of monohydroxy linoleic 
acid; (2) a cytochrome-catalyzed decomposition of the hydroperoxide by the 
mitochondrial and microsomal fractions in which a complex range of products 
was formed presumably as a result of the interaction of free-radical 
intermediates. 
The mechanism of hydroperoxide decomposition by liver microsomes 
was recently investigated by Hrycay and O'Brien (74) who identified cyto-
chrome P-450 as the microsomal peroxidase responsible for the decomposition 
of a lipid peroxide substrate. The peroxidase activity of hepatic microsomes 
was measured using TMPD as the electron donor. Cytochrome P-450 is 
distributed in a large variety of tissues (17) and could therefore be an 
important intracellular site for the decomposition of various hydroperoxides. 
Aim of the Thesis 
The aim of the present work was to investigate the mechanism 
by which steroid and other organic hydroperoxides are decomposed by the 
cytochrome P-450-dependent oxidase system of microsomal fractions in order 
to assess the role of hydroperoxides as possible intermediates in microsomal 
hydroxylation reactions. 
CHAPTER I 
CYTOCHROME P-450 AS A MICROSOMAL PEROXIDASE IN STEROID 
HYDROPEROXIDE DECOMPOSITION 
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In the following chapter, the decomposition of steroid and 
other organic hydroperoxides by microsomal fractions will be investigated 
using TMPD as an electron donor. 
MATERIALS AND METHODS 
Materials 
Steroids, nucleotides, ~-octylamine, vitamin E, heme compounds, 
trypsin, trypsin inhibitor, ~-hydroxymercuribenzoate, and GSH were purchased 
from Sigma. Phenacetin and TMPD were from British Drug Houses, Toronto. 
Cumene hydroperoxide and aminopyrine were supplied by Matheson, Coleman 
and Bell. Lubrol vlX was kindly donated by Imperial Chemical Industries, 
Providence, Rhode Island. 2-Phenyl-2-propanol was obtained from Aldrich 
Chemical Company, Milwaukee. All other reagents were of the highest grade 
commercially available. 
Preparation of steroid hydroperoxides 
The 17a-hydroperoxide derivatives of progesterone, pregnenolone, and 
allopregnenolone were prepared by the method of Bailey et al.(75). Cholesterol 
7a-, 78-, 20a-, 25-, and 26-hydroperoxides as well as cholest-4-en-3-one 
6 -hydroperoxide were prepared by autoxidation of cholesterol as previously 
described (76-78). Their purity was verified by tlc, gc, ms, or chemical 
analysis (75-78). 
Preparation of linoleic acid hydroperoxide 
Linoleic acid hydroperoxide was prepared by aerial oxidation of 
- 20 -
linoleic acid and purified by silica gel chromatography as described by 
O'Brien (79). The concentration was determined by measuring the -absorbance 
2 3 3 . h 1 . . . f f . . f 2 5 2 5 -lmM-l at nm 1n et ano us1ng an ext1nct1on coe 1c1ent o . em . 
Preparation of microsomes 
Liver microsomes were prepared from perfused livers of Sprague-
Dawley rats (250-350 g) as previously described (74). The microsomes were 
suspended in 0.3 M sucrose- 2 mM EDTA (pH 7.4) and used within 24 hours of 
preparation. No loss in activity occurred during this period when microsomes 
were stored at 0°. Adrenocortical microsomes were preuared from bovine adrenal 
glands. The adrenals were defatted, demedullated, and the cortical tissue 
washed with cold isotonic KCl to remove adsorbed hemoglobin. The cortical 
tissue was homogenized in 4 volumes of cold sucrose-EDTA solution, the 
homogenate centrifuged at 14,000 a for 20 minutes and the pellet discarded. 
The supernatant was centrifuged at 105,000 a for 60 minutes, the microsomal 
pellet was resuspended in 0.15 M KCl- 2 mM EDTA (pH 7.4) and centrifuged 
as above. The washed microsomes were finally suspended in 0.3 M sucrose -
2 mM EDTA (pH 7.4) and used within 24 hours of preparation. Microsomes 
from other tissues of the rat were obtained by a similar procedure as was 
used for the preparation of adrenocortical microsomes. 
Assay of peroxidase activity 
Peroxidase activity in microsomal fractions was assayed at 23° C 
with TMPD as hydrogen donor (74) using a reaction medium normally conaaining 
0.033 M sodium phosphate buffer (pH 7.4), 1.5 mM EDTA, 0.27 M sucrose, 
0.2 mM TMPD, 1 mg microsomal protein and 0.05 mM organic hydroperoxide in a 
final volume of 3 ml. The rate of TMPD oxidation was followed spectrophoto-
metrically at 610 nm in the first minute of reaction by measuring the 
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formation of Wurster's blue free radical (80). Reaction rates were 
corrected for TMPD oxidation in the absence of hydroperoxide. An extinct-
-1 -1 ion coefficient for TMPD of 11.6 em mM (80) was employed in the cal-
culation of the reaction rates. The use of large concentrations of TMPD 
in the assay medium was to be avoided because of the relatively high rate 
of autoxidation of TMPD at pH 7.4 (81). 
When the peroxidase reaction was measured using adrenocortical 
microsomes, a substantial control rate of TMPD oxidation due to mitochon-
drial contamination, as evidenced by the presence of cytochrome oxidase 
activity, was observed in the absence of hydroperoxide. Therefore, assays 
were carried out in the presence of 0.1 mM sodium cyanide which reduced the 
control rate to an almost negligible amount. 
Steroid hydroperoxides were dissolved in ethanol prior to use 
and microliter amounts were added to the assay medium. Because of the poor 
solubility in aqueous medium of the steroid hydroperoxides, assays were 
carried out in the presence of 0.27 M sucrose to assist in the solubilizat-
ion of the hydroperoxides. 
Analytical Methods 
Cytochromes P-450, P-420, and b 5 were determined as described 
previously (74). Protein was measured by the method of Lowry et al (82) 
using bovine serum albumin as standard. 
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RESULTS 
The TMPD-peroxidase assay 
The peroxidase activity of microsomal fractions and heme 
compounds was investigated using TMPD as hydrogen donor and cumene hydro-
peroxide and a wide variety of steroid hydroperoxides as substrates. The 
oxidation of TMPD was followed at 610 nm by measuring the rate of formation 
of Wurster's blue free radical. This is a new peroxidase assay and has 
the advantage of high sensitivity, a product that is stable over a wide pH 
range, good stoichiometry, and an almost negligible control rate in the 
absence of hydroperoxide or catalyst (74), 80). Other hydrogen donors used 
in peroxidase assays such as guaiacol, pyrogallol, ~-dianisidine, hydro-
quinone, catechol, and resorcinol gave no satisfactory reaction rate for 
microsomal peroxidase with the concentration of hydroperoxide normally 
employed in the TMPD assay method. 
Kinetic properties of microsomal peroxidase 
The kinetic properties of microsomal peroxidase were investigated 
using liver or adrenocortical microsomes as the enzyme source and cumene 
hydroperoxide and the 17a-hydroperoxide derivatives of progesterone and 
pregnenolone as substrates. The reaction rate with cumene hydroperoxide 
was linear for the first 5 minutes of reaction whereas the rate with 
steroid hydroperoxides was non-linear with time because of product inhibit-
ion. Maintaining the TMPD concentration at 0.2 mM, the reaction rate was 
found to be first-order with respect to microsomal protein concentration 
(Fig. 1) and first-order with respect to cumene hydroperoxide concent~ation 
(Fig. 2) in the concentration range 0.05 - 1.0 mM*. Using the 17a-
* Higher concentrations produced very large reaction rates which could 
not be measured accurately. 
Figure 1. Effect of microsomal protein concentration on the rate 
of TMPD oxidation by hydroperoxides. 
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Peroxidase activity was measured at 23° with TMPD as hydrogen donor 
at 610 nm in a 3 ml system consisting of 0.033 M sodium phosphate 
buffer - (pH 7.5), 1 mM EDTA, 0.27 M sucrose, 0.2 mM TMPD, varying 
amounts of microsomal protein and 0.2 mM cumene hydroperoxide or 
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0.05 mM progesterone 17a-hydroperoxide or pregnenolone 17a-hydroperoxide. 
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Figure 2. Effect of hydroperoxide concentration on the rate of 
catalyzed TMPD oxidation. 
50 
10 
Assay _conditions were similar to those in Figure 1 except that 
1 mg liver microsomal protein and 2.2 mg adrenocortical micro-
somal protein were used and the hydroperoxide concentration 
varied. 
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hydroperoxide derivatives of progesterone and pregnenolone as substrates, 
the reaction rate showed saturation kinetics with increasing concentrations 
of hydroperoxide (Fig. 2). When the concentration of TMPD was varied, 
the reaction rate showed saturation kinetics with increasing concentra-
tions of TMPD (Fig. 3). The range of steroid hydroperoxide concentrations 
examined was 0.01 - 0.1 mM. Concentrations exceeding 0.1 mM could not be 
used as the steroid hydroperoxides came out of aqueous solution under the 
specified conditions of the peroxidase assay. 
The effect of pH on the peroxidase activity of liver microsomes 
using cumene hydroperoxide and progesterone 17a-hydroperoxide as sub-
strates is illustrated in Fig. 4. The reaction rate with cumene hydro-
peroxide showed a pH optimum in the range 6.5 - 7.0. A pH optimum of 
between 6.8 and 7.6 was obtained with progesterone 17a-hydroperoxide. 
Hydroperoxide specificity of microsomal peroxidase 
The hydroperoxide specificity of microsomal peroxidase is pre-
sented in Table 2. It is seen that the 17a-hydroperoxide derivatives of 
progesterone and pregnenolone were very effective substrates with either 
liver or adrenocortical microsomes as the enzyme source. The cholesterol 
hydroperoxides were found to be much less effective substrates for micro-
somal peroxidase, possibly because the cholesterol side chain sterically 
hinders the interaction between the hydroperoxide moiety and the heme 
catalyst. 
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Figure 3. Effect of TMPD concentration on the rate of cata£yzed TMPD 
oxidation by hydroperoxides. 
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Assay conditions were similar to those in Figure 1 except that 
1 mg liver microsomal protein and 2.2 mg adrenocortical micro-
somal protein were used and the concentration of TMPD varied. 
Reaction ·rates were corrected for TMPD oxidation in the absence 
of h droperoxide. 
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Figure 4. Effect of pH on the peroxidase activity of liver microsomes. 
The peroxidase reaction was measured in a 3 ml solution contain-
ing 1 mM EDTA, 0.27 M sucrose, 0.2 mM TMPD, 1 mg microsomal pro-
tein, and 0.2 mM cumene hydroperoxide or 0.05 mM progesterone 
17~-hydroperoxide. The pH was adjusted with HCl or NaOH. At pH 
values ·of between 4.2 and 4.8, an increase in turbidity due to 
protein aggregation was observed prior to addition of hydroper-
oxide. In these cas.es, the reaction rate was measured by 
addition of hydroperoxide after there was no more increase in 
turbidity. 
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TABLE 2 
HYDROPEROXIDE SPECIFICITY OF MICROSOMAL PEROXIDASEa 
Peroxidase Activity 
Liver Adrenocortical 
Hydroperoxide Microsomes Micro somes 
Progesterone 17a-hydroperoxide 92 31 
Pregnenolone 17a-hydroperoxide 80 30 
Allopregnanolone 17a-hydroperoxide 76 27 
Linoleic acid hydroperoxide 75 25 
Cumene hydroperoxide 34 12 
Cholesterol 7S-hydroperoxide 30 17 
Cholest-4-ene-3-one 6S-hydroperoxide 30 10 
Cholesterol 7a-hydroperoxide 22 9 
Cholesterol 25-hydroperoxide 17 9 
Cholesterol 26-hydroperoxide 15 9 
Cholesterol 20a-hydroperoxide 12 5 
a Assay medium contained 0.033 M sodium phosphate (pH 7.4), 1.5 mM EDTA, 
0.27 M sucrose, 0.2 mM TMPD, 2 mg microsomal protein, and 0.05 mM hydro-
peroxide in a 3 ml volume. The peroxidase activity of adrenocortical 
microsomes was measured in the presence of 0.1 mM sodium cyanide to 
inhibit the control TMPD oxidase rate. Reaction rates were corrected 
for TMPD oxidation in the absence of hydroperoxide and are expressed as 
~A610 nm/min/~ mole P-450. 
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Tissue distribution of microsomal peroxidase activity 
In Table 3 is shown the tissue distribution of microsomal 
peroxidase activity. It is seen that microsomal fractions from tissues 
which contained high amounts of cytochrome P-450 per milligram protein 
(e.g. liver, adrenal gland) were the most active in catalyzing the 
peroxidase reaction whereas microsomes from tissues that contained little 
or no cytochrome P-450 showed either weak activity or no activity at all. 
Adrenal microsomes were about 4 times less effective than liver microsomes 
in catalyzing the peroxidase reaction with both fractions containing 
similar cytochrome P-450 levels. 
The properties of microsomal peroxidase from rat liver and 
bovine adrenal cortex were next examined in detail. 
Inhibition of microsomal peroxidase activity by various reagents 
The effect of various reagents on the peroxidase activity of 
liver microsomes using cumene hydroperoxide as substrate is presented in 
Table 4. Cumene hydroperoxide was chosen as the model substrate for 
inhibitor studies because it is sufficiently soluble in water (84) to permit 
study of the peroxidase reaction. It is seen that heat treatment of micro-
somes completely abolished the activity which indicates the enzymic nature 
of the peroxidase reaction. Since EDTA did not affect the reaction rate, 
this suggests that weakly bound inorganic metal ions are unlikely to be 
involved. Sodium azide (10 mM) produced a 20% inactivation whereas N2 
and sodium fluoride exhibited little effect. CO produced no appreciable 
inhibition which indicates that the peroxidase activity of microsomes is 
not due to contaminating hemoglobin. No significant inhibition was 
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TABLE 3 
TISSUE DISTRIBUTION OF MICROSOMAL PEROXIDASE ACTIVITYa 
Source of Mlcrosomes P-450 Content Peroxidase Activity 
Rat liver 0.70 0.170 
adrenal gland 0.53 0.040 
kidney 0.25 0.010 
lung 0.05 0.030 
testis 0.02 0.008 
small intestine 0.02 0.007 
heart 0 0 
skeletal muscle b 0 0 
brain 0 0 
Bovine adrenal cortex 0.60 0.030 
a 
b 
Assay system contained 0.067 M sodium phosphate (pH 7.4), 1 mM EDTA, 
0.2 mM TMPD, 1 mg microsomal protein, 0.1 mM sodium cyanide, and 0.2 mM 
cumene hydroperoxide in a final volume of 3 ml. Peroxidase activity is 
expressed as ~A610 nm/min/ mg protein whereas P-450 content is given as 
nmoles/mg protein. 
The hind legs of the rat were used for the source of skeletal muscle. 
TABLE 4 
EFFECT OF VARIOUS MODIFIERS ON HEPATIC MICROSOMAL 
PEROXIDASE ACTIVITYa 
Modifier % Inhibition 
Heat (80° for 5 min) 95 
Sodium azide (10 mM) 20 
C b .d b ar on monoxl e 4 
N. b ltrogen 3 
EDTA (10 mM) 7 
Sodium fluoride (10 mM) 4 
2-phenyl-2-propano1 (2 mM) 2 
a 
b 
The assay medium contained 0.067 M sodium phosphate (pH 7.5), 1 mM 
EDTA, 0.2 mM TMPD, 1 mg liver microsomal protein, 0.2 mM cumene 
hydroperoxide, and specified cone. of various modifiers in a 3 ml 
reaction volume. The specific activity of microsomal peroxidase 
before addition of modifier, expressed as ~A610 nm/min/mg protein, 
was 0.17. 
An aerobic sample cuvette was gassed for 15 min with nitrogen 
(99.99% pure) or CO that had been previously passed through a 
deoxygenating medium (83). 
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obtained when an excess of 2-phenyl-2-propanol, the hydroxy derivative 
and main decomposition product of cumene hydroperoxide, was added to the 
peroxidase assay. 
Similar inhibitions by these modifiers were observed when 
adrenocortical microsomes were employed as the enzyme source. 
Inhibition of peroxidase activity by reagents that convert cytochrome P-450 
to cytochrome P-420 
The conversion of microsomal cytochrome P-450 into its inactive 
P-420 form is brought about by a wide variety of reagents such as proteases, 
sulfhydryl reagents, lipophilic substances, surface-active agents, strong 
oxidizing agents, and acidic or alkaline pH (11, 26, 37, 50). The effects 
of several of these reagents on microsomal peroxidase activity using cumene 
hydroperoxide as substrate are illustrated in Table 5. The results strongly 
suggest that the conversion of microsomal cytochrome P-450 to cytochrome 
P-420 by various reagents is responsible for the observed inhibition of 
peroxidase activity. 
Similar inhibitions by these P-450 modifiers were obtained when 
adrenocortical microsomes were substituted for liver microsomes or when 
progesterone 17a-hydroperoxide was used as substrate. 
Inhibition of peroxidase activity by type I and type II compounds 
Compounds termed type I, type II, and modified type II substrates 
interact specifically with cytochrome P-450 to produce characteristic 
spectral changes (34, 35). The effects of several of these substances on 
the peroxidase activity of liver microsomes is shown in Table 6. The results 
indicate that these compounds effectively inhibited the peroxidase 
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TABLE 5 
INHIBITION OF HEPATIC MICROSOMAL PEROXIDASE ACTIVITY BY REAGENTS 
THAT CONVERT CYTOCHROME P-450 TO CYTOCHROME P-420 a 
P-450 Modifier % Inhibition % P-420 Formed 
None 0 0 
N-bromosuccinimide (0.4 mM) 50 44 
Iodine (0.2 mM) 60 45 
~-hydroxymercuribenzoate (0.5 mM) 66 67 
Sodium dodecyl sulfate (0.1%) 90 95 
Lubrol WX (1%) 62 73 
Urea (4 M) 38 44 
T • b ryps1n 54 62 
n-Propanol 85 100 
a 
b 
Liver microsomes at a protein cone. of 5 mg/ml were incubated at 20° 
for 15 min with specified cone. of various P-450 modifiers in 0.1 M 
sodium phosphate buffer (pH 7.4) containing 1 mM EDTA and 0.05 M sucrose. 
After incubation samples were diluted with an equal volume of 0.1 M 
sodium phosphate buffer (pH 7.4), peroxidase activity using 0.2 mM cumene 
hydroperoxide measured, and the extent of conversion of P-450 to P-420 
determined. 
Liver microsomes (10 mg protein/ml) were incubated at 23° for 90 minutes 
with 50 ~ g trypsin/mg protein in 0.04 M sodium phosphate buffer (pH 7.4) 
containing 2 mM EDTA and 0.3 M sucrose. Peroxidase activity and the 
extent of conversion of P-450 to P-420 were determined. 
TABLE 6 
INHIBITION OF HEPATIC MICROSOMAL PEROXIDASE ACTIVITY BY TYPE I AND TYPE II LIGANDS a 
Type I Ligand 
Androstenedione (0.1 mM) 
Testosterone (0.1 mM) 
17s-estradiol (0.1 mM) 
Aminopyrine (5 mM) 
Hexobarbital (0.5 mM) 
Linoleic acid (0.1 mM) 
% 
Inhibition 
65 
65 
50 
45 
34 
34 
Type II Ligand 
Aniline (10 mM) 
Imidazole (1 mM) 
Pyridine (10 mM) 
n-Octylamine (0.05 mM) 
% 
Inhibition 
83 
82 
82 
40 
Modified % 
Type II Ligand Inhibition 
Sodium cyanide (1 mM) 56 
Corticosterone (0.1 mM) 55 
Phenacetin b (1 mM) 55 
Ethanol (7%) 68 
Methanol (7%) 66 
a Peroxidase activity was measured in the presence of specified amounts of various type I and type II ligands as 
described in Table 4. 
b Phenacetin = ~-ethoxyacetanilide. 
reaction. 
In Table 7 is illustrated the effect of various type I and 
type II ligands on adrenocortical microsomal peroxidase activity using 
progesterone 17a-hydroperoxide as substrate. The peroxidase reaction 
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was inhibited by 17a-hydroxyprogesterone, the main decomposition product 
of progesterone 17a-hydroperoxide, suggesting a feedback mechanism of 
inhibition. Other type I and type II ligands also produced strong inhibi-
tory effects. 
Jefcoate et al (85) investigated the binding of the type II 
ligand, n-octylamine, to the low spin and high spin forms of oxidized 
cytochrome P-450 present in liver microsomes. Two binding constants for 
n-octylamine of 0.05 mM and 0.034 mM were obtained for low spin P-450 and 
a binding constant of 0.3 mM was found for high spin P-450. In contrast 
to liver microsomes, only the low spin form of oxidized cytochrome P-450 
was detected in adrenocortical microsomes and a binding constant for 
n-octylamine of about 1 mM was observed (85). Our results indicate a 40% 
inhibition of hepatic microsomal peroxidase activity by 0.05 mM n-octylamine 
(Table 6) and a 55% inactivation of adrenocortical microsomal peroxidase 
activity by 1 mM n-octylamine (Table 7), suggesting a possible involvement 
of low spin cytochrome P-450 in the peroxidase mechanism of hepatic and 
adrenocortical microsomes. 
Inhibition of peroxidase activity by cyanide 
Cyanide has been reported to inhibit several cytochrome P-450-
dependent oxidation reactions (11, 12, 58, 59). The effect of cyanide on 
the microsomal TMPD-peroxidase reaction is illustrated in Fig. 5. The 
TABLE 7 
INHIBITION OF ADRENOCORTICAL MICROSOMAL PEROXIDASE ACTIVITY BY 
TYPE I AND TYPE II LIGANDS a 
Type I Ligand % Inhibition 
Testosterone (0.1 mM) 44 
Progesterone (0.1 mM) 39 
17a-Hydroxyprogesterone (0.1 mM) 35 
Androstenedione (0.1 mM) 34 
Deoxycorticosterone (0.1 mM) 28 
Type II Ligand 
n-Octylamine (1 mM) 55 
Imidazole (2 mM) 40 
Corticosterone (0.1 mM) 28 
a Assay medium contained 0.033 M sodium phosphate (pH 7.5), 1.5 mM 
EDTA, 0.27 M sucrose, 0.1 mM sodium - cyanide, 0.2 mM TMPD, 2 mg 
adrenocortical microsomal protein, 0.05 mM progesterone 17a-hydro-
peroxide, and specified concentrations of modifiers. The specific 
activity of microsomal peroxidase before addition of ligands, 
expressed as AA610 nm/min/mg protein, was 0.016. 
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Figure 5. Cyanide inhibition curve for microsomal TMPD-peroxidase 
activity. 
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The reaction was measured in a 3 ml system containing 0.067 M 
sodium phosphate buffer (pH 7.5), 1 mM EDTA, 0.2 mM TMPD, 1 mg 
liver microsomal protein, indicated amounts of potassium cyanide, 
and 0.2 mM cumene hydroperoxide. 
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results show that cyanide was a fairly effective inhibitor of the 
reaction, a 50 percent inhibition occurring at a cyanide concentration 
of about 0.8 mM. 
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Spectral changes during hydroperoxide interaction with microsomal fractions 
Fig. 6 presents the spectral changes induced by progesterone 
17a-hydroperoxide interaction with adrenocortical microsomal suspensions. 
Difference spectra were carried out in the presence of 0.15 M sucrose to 
assist in the solubilization of the hydroperoxide. However, larger amounts 
of sucrose were to be avoided since polyols are known to decrease the 
magnitude of the type I spectral change induced by various steroids (86). 
The initial difference spectrum of progesterone 17a-hydroperoxide showed a 
broad peak at about 412 nm and a trough at 430 nm. After 15 minutes a 
type I difference spectrum with a peak at about 390 nm. and a trough at 
422 nm was obtained. This spectrum was fully developed after 30 minutes 
of reaction and was identical to the type I difference spectrum produced by 
interaction of 0.05 mM 17a-hydroxyprogesterone with a similar concentration 
of adrenocortical microsomal protein. Extraction of the reaction medium 
with methylene chloride at 45 minutes and analysis of the products by tlc, 
gas chromatography, and mass spectrometry (as described in Chapter 2) 
established that progesterone 17a-hydroperoxide had been converted to 
17a-hydroxyprogesterone in 65% yield. A small amount of androstenedione 
(20%) was also formed and the rest was unconverted hydroperoxide. 
Both 17a-hydroxyprogesterone and androstenedione produce type I 
spectral changes when added to adrenocortical microsomal suspensions but 
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Figure 6. Spectral changes produced during progesterone 17a-hydroperoxide 
decomposition by adrenocortical microsomes. 
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In each of two cuvettes (1 em light path) was placed 3 ml of a 
microsomal suspension (2.5 mg protein/ml) · containing 0.067 M 
sodium phosphate buffer (pH 7.5), 1.5 mM EDTA, 0.15 M sucrose 
and the baseline was recorded using an AMINCO- CHANCE 
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spectrophotometer. To the sample cuvette was added 20 ~1 
of an ethanolic solution of progesterone 17a-hydroperoxide 
(final concentration 0.05 mM), the reference cuvette received 
an equivalent volume of ethanol, and the difference spectrum 
was recorded at 23° at indicated time intervals. After 30 
min, the reaction medium was extracted with methylene chloride 
and the products analyzed. 
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the magnitude of the spectral change produced by 17a -hydroxyprogesterone 
is about 5 times greater than that produced by an equivalent amount of 
androstenedione (12). The fact that 17a-hydroxyprogesterone was the 
major reaction product formed during progesterone 17a -hydroperoxide 
decomposition by adrenocortical microsomes and because the hydroxy-
steroid produces a much more intense spectral change than does andro-
stenedione suggests that the major portion of the type I-induced 
difference spectrum produced during the course of progesterone 17a-
hydroperoxide decomposition by adrenocortical microsomes is the result 
of the interaction of newly-formed 17a-hydroxyprogesterone with microsomal 
cytochrome P-450. 
No such spectral changes were observed when progesterone 17a -
hydroperoxide or cumene hydroperoxide were incubated with liver microsomal 
suspensions. 
Comparison of adrenocortical microsomal peroxidase activity with the rate 
of progesterone 17a-hydroperoxide reduction by microsomes 
The peroxidase activity of adrenocortical microsomes as measured 
by TMPD oxidation and using 0.05 mM progesterone 17a-hydroperoxide as sub-
strate gave a rate of approximately 4 nmoles/min/mg protein. The rate of 
conversion of progesterone 17a-hydroperoxide to 17a-hydroxyprogesterone by 
adrenocortical microsomes was found to be approximately 1.5 nmoles/min/mg 
protein. The latter value was calculated using the ~A (390-420nm) after 
3 minutes of reaction (Fig. 5) and employing the relationship 12 ~M 17a-
hydroxyprogesterone yields a ~A (390-420 nm) = 0.017/cm/mg protein (12). 
Effect of phenobarbital or 3-methylcholanthrene pretreatment of rats on 
microsomal peroxidase activity 
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Treatment of rats or rabbits with phenobarbital or 3-methyl-
cholanthrene is known to cause a marked elevation in the specific content 
of hepatic microsomal cytochrome P-450 without appreciably affecting the 
concentration of cytochrome b 5 (41). The cytochrome P-450 from liver 
microsomes of induced animals differs in several of its physical and 
biochemical properties from normal cytochrome P-450 (45, 46). Whether the 
new P-450 synthesized in the liver in response to phenobarbital or 3-methyl-
cholanthrene pretreatment possesses similar peroxidase properties to normal 
P-450 was next examined. The results (Table 8) show that the specific 
activity of microsomal peroxidase using progesterone 17a-hydroperoxide as 
substrate was enhanced 2.8-fold by in vivo phenobarbital treatment. This 
activation was accompanied by a 3-fold increase in P-450 content whereas 
cytochrome b 5 showed only a 1.3-fold increase. Injection of rats with 
3-methylcholanthrene increased the specific activity of microsomal peroxi-
dase 1.4-fold, with progesterone 17a-hydroperoxide as substrate, and this 
stimulation was accompanied by a similar elevation in P-450 content whereas 
cytochrome ~ remained virtually unaffected. 
In contrast, pronounced differences in the peroxidase activity 
of microsomal cytochrome P-450 from uninduced and phenobarbital or 
3~ethylcholanthrene-induced rats were obtained using cumene hydroperoxide 
as substrate (Table 8). The specific activity of microsomal peroxidase was 
enhanced 19-fold by phenobarbital treatment whereas the specific content 
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TABLE 8 
EFFECT OF PHENOBARBITAL OR 3-METHYLCHOLANTHRENE PRETREATMENT 
OF RATS ON MICROSOMAL PEROXIDASE ACTIVITY a 
Pretreatment Cytochrome E,.5 Cytochrome P-450 Peroxidase Activity 
nmoles/mg 
protein 
nmoles/mg 
protein 
~A610 nm/min/mg protein 
progesterone cumene 
17a-hydro- hydro-
peroxide peroxide 
Saline 0.40 0.60 0.062 0.021 
Phenobarbital 0.51 1.80 0.171 0.411 
Olive Oil 0.36 0.58 0.050 0.023 
3-Methylcholanthrene 0.40 0. 77 b 0.070 0.015 
a 
b 
Male albino rats (275-325 g) were injected intraperitoneally with sodium 
phenobarbital (50 mg/kg) in saline twice daily for 5 days or with 3-methyl-
cholanthrene (20 mg/kg) in olive oil once daily for 4 days. Control rats 
received an equivalent volume of saline or olive oil. The animals were 
sacrificed 24 hours after the last injection, microsomes were prepared 
from perfused livers, peroxidase activity and cytochrome E5 content measured 
as described in Materials and Methods. The P-450 content of liver micro-
somes from rats treated with saline, phenobarbital, mlive oil was deter-
mined from the CO-difference spectrum of dithionite-treated samples using 
an extinction coefficient of 91 cm-1 mM-1 (87). Determinations were made 
on the pooled livers of 3 rats. 
The CO-complex of reduced P-450 in liver microsomes from rats treated with 
3-methylcholanthrene exhibited an absorption maximum at 448 run. An 
extinction coefficient of 103 cm-l mM-l (88) was used to estimate the con-
centration of the hemoprotein. 
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of P-450 showed only a 3-fold increase. On the other hand, treatment of 
rats with 3-methylcholanthrene produced a 35% inactivation of microsomal 
peroxidase activity whereas the P-450 content was enhanced 1.4-fold. This 
result suggests that 3-methylcholanthrene-induced P-450 is less active as 
a peroxidase for cumene hydroperoxide than is normal P-450. 
Effectiveness of partially purified cytochrome P-450 and various heme 
catalysts for peroxidase activity 
Table 9 compares the peroxidase activity of hemoprotein P-450 
with other heme catalysts using a variety of hydroperoxide substrates. 
The two hemoproteins, cytochrome b 5 and hemoprotein P-450, account for 
virtually all of the protoheme in the microsomal fraction of liver (17, 87). 
Selective solubilization of cytochrome b 5 from the microsomal membrane by 
protease digestion has proven to be a valuable approach in obtaining 
partially purified cytochrome P-450 preparations. In addition to cyto-
chrome b 5 release, the flavoprotein NADPH-cytochrome c reductase is also 
completely solubilized by the treatment. The pellet preparations have 
been termed "P-450 particles" because of their high specific content of 
P-450 relative to cytochrome b 5 • 
In this study, "P-450 particles" were prepared by anaerobic di-
gestion of rat liver microsomes with trypsin essentially by the method of 
Ichikawa and Yamano (90). The preparation was found to contain about 0.7 
nmoles P-450 per milligram protein and a negligible amount of cytochrome b 5 
(i.e., 5% of total protoheme). When tested for peroxidase activity with 
various hydroperoxide substrates, the partially purified P-450 preparation 
exhibited a similar peroxidase activity per mole of P-450 as did original 
Heme Catalyst 
Microsomal P-450 b 
Partially purified P-450 
Hematin 
Methemoglobin 
Cytochrome £ 
High spin P-420 d 
Low spin P-420 d 
TABLE 9 
a COMPARATIVE EFFICIENCIES OF HEME CATALYSTS FOR PEROXIDASE ACTIVITY 
Peroxidase activity 
(moles TMPD oxidized/min/mole of heme) 
Progesterone Pregnenolone Cumene 
17a-hydroperoxide 17a-hydroperoxide hydroperoxide 
27 23 10 
c 
25 19 9 
240 9 5 
6 2 2 
3 2 2 
<3 <2 <2 
<3 <2 <2 
Linoleic acid 
hydroperoxide 
23 
30 
156 
122 
96 
200 
60 
a The peroxidase activities of various heme catalysts were measured at 23° by following the oxidation of TMPD at 
b 
c 
610 nm in a 3 ml solution containing 0.033 M sodium phosphate buffer (pH 7.5), 1 mM EDTA, 0.25 M sucrose, 0.2 mM 
TMPD, suitable concentrations of heme catalysts, and 0.05 mM hydroperoxide. Reaction rates were first order with 
respect to heme catalyst and were calculated in terms of moles TMPD oxidized/min/mole of heme using an extinction 
coefficient fur TMPD of 11.6 cm-1 mM-1 (80). 
Liver microsomes containing 0.6 nmoles P-450/mg protein were used in the determinations. 
"P-450 particles" containing 0.7 nmoles P-450/mg protein were used in the determinations. 
d High spin and low spin P-420 was prepared essentially as described previously (89). 
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microsomes. Hence, cytochrome b 5 does not appear to be involved in the 
peroxidase mechanism of liver microsomes. 
Hemoprotein P-450 was an effective peroxidase for most hydroper-
oxides tested (Table 9). Hematin exhibited a high peroxidatic activity 
towards progesterone 17 a-hydroperoxide. A logical explanation for the 
effectiveness of hematin in decomposing progesterone 17a-hydroperoxide could 
be that the heme iron of the hematin molecule, because it is readily exposed 
and not shielded by a protein residue, can easily interact with the hydro-
peroxide and catalyze decomposition. On the other hand, hematin showed a 
weak peroxidatic activity towards pregnenolone 17a-hydroperoxide and cumene 
hydroperoxide probably because these hydroperoxides do not bind readily to 
the heme compound and consequently are not decomposed. A similar explanation 
may hold for the ineffectiveness of methemoglobin and cytochrome ~ in decom-
posing these hydroperoxides. High spin or low spin cytochrome P-420 was 
ineffective in decomposing cumene hydroperoxide and the steroid hydroperoxides 
but acted as an effective peroxidase for linoleic acid hydroperoxide (89). 
Destruction of cytochrome P-450 by hydroperoxides 
Previous studies (74) reported the destruction of hemoprotein P-450 
upon incubation of liver microsomes with linoleic acid hydroperoxide. In 
this study, the effect of other hydroperoxides on hepatic microsomal P-450 
was investigated. The results (Table 10) show that incubation of 30 moles 
cumene hydroperoxide per mole of P-450 resulted in a 46% destruction of the 
hemoprotein at pH 7.5. Various hydrogen donors such as GSH, NADH, NADPH, 
TMPD, and ascorbate protected cytochrome P-450 effectively from damage 
by the hydroperoxide, possibly by reducing the oxidizing species involved 
TABLE 10 
EFFECT OF VARIOUS AGENTS ON THE DESTRUCTION OF 
CYTOCHROME P-450 BY CUMENE HYDROPEROXIDE a 
Addition % P-450 remaining 
None 
Cumene hydroperoxide 
GSH + cumene hydroperoxide 
TMPD + cumene hydroperoxide 
Hydroquinone + cumene hydroperoxide 
Trimethylhydroquinone + cumene hydroperoxide 
NADH + cumene hydroperoxide 
NADPH + cumene hydroperoxide 
Ascorbate + cumene hydroperoxide 
Vitamin E + cumene hydroperoxide 
Testosterone b + cumene hydroperoxide 
b Progesterone + cumene hydroperoxide 
100 
54 
96 
95 
95 
95 
91 
90 
83 
78 
78 
75 
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a A mixture of liver microsomes (4.8 mg protein/ml) containing 0.6 nmoles 
b 
P-450 per mg protein was incubated for 15 min at 23° with 0.1 mM cumene 
hydroperoxide in 0.033 M sodium phosphate buffer (pH 7.5) containing 2 mM 
EDTA and 0.27 M sucrose in a final volume of 3 ml. After incubation the 
sample was treated with an equal volume of a mixture consisting of 0.1 M 
sodium phosphate buffer (pH 7.5), 50% glycerol, 2 mM EDTA and 0.4% lubrol 
WX. The CO-difference spectrum of dithionite-treated samples was measured 
and the destruction of P-450 determined. The effect of various reagents 
(2 mM) on P-450 destruction by cumene hydroperoxide was determined by pre-
incubation of the P-450 suspension with the agents for 2 min prior to 
addition of hydroperoxide. 
The concentration used was 0.2 mM. 
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in P-450 destruction. Antioxidants such as hydroquinone and vitamin E 
also were effective protecting agents. Steroids such as testosterone 
and progesterone offered some protection to P-450 (Table ~0) whereas 
type II ligands such as imidazole, n-octylamine , and cyanide afforded 
no appreciable protection. Incubation of 30 moles of progesterone 17a-
hydroperoxide per mole of P-450 under identical conditions proquced a 
25% inactivation of cytochrome P-450. 
The susceptibility of adrenocortical microsomal P-450 to 
destruction by progesterone 17a-hydroperoxide was next determined by in-
cubating a suspension of adrenocortical microsomes (1.9 mg protein/ml) 
with 0.2 mM hydroperoxide for 30 minutes at 20° in 0.1 M sodium phosphate 
buffer (pH 7.5) containing 0.03 M sucrose and 0.2 mM EDTA in a finalvolume 
of 3 ml. It was found that incubation of 300 moles of progesterone 17a-
hydroperoxide per mole of P-450 resulted in only a 15% destruction of the 
hemoprotein at pH 7.5. GSH (1 mM) protected cytochrome P-450 completely 
from destruction by the hydroperoxide. 
These results illustrate that hepatic microsomal P-450 is much 
more susceptible to destruction by progesterone 17a-hydroperoxide than is 
adrenocortical microsomal P-450. 
CHAPTER II 
PRODUCTS OF DECOMPOSITION OF PREGNENE 
17a-HYDROPEROXIDES AND CUMENE HYDROPEROXIDE BY 
MICROSOMAL FRACTIONS 
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CHAPTER LI: PRODUCTS OF DECOMPOSITLON OF PREGNENE 17a-HYDROPEROXIDES AND 
CUMENE HYDROPEROXIDE BY MICROSOMAL FRACTIONS 
In Chapter I, the pregnene 17a-hydroperoxides were found to act 
as effective substrates for microsomal cytochrome P-450. This chapter 
presents a detailed analysis of the products formed when these steroid 
hydroperoxides were exposed to microsomal preparations. In addition the 
decomposition products of cumene hydroperoxide were also determined. 
MATERIALS AND METHODS 
Materials 
Steroids, nucleotides, and heme compounds were obtained from 
Sigma. Silica gel HF 254 was purchased from E. Merck and plastic strips, 
precoated with silica gel N-HR, were supplied by Brinkmann Instruments. 
All solvents were predistilled. 
Preparation of steroid hydroperoxides 
Progesterone 17a-hydroperoxide and pregnenolone 17a-hydroperoxide 
were prepared by the method of Bailey et al (75). Their purity was verified 
by thin layer chromatography, visualization of the developed spot with 
N,N-dimethyl-~-phenylenediamine reagent (91), and analysis of their character-
istic ~ - ms decomposition patterns (see pages 58 - 60) which were similar 
to those obtained by Tan and coworkers (92). 
Incubation of steroid hydroperoxides with microsomal fractions 
Standard incubations were conducted in glass-stoppered 25 ml test 
tubes. The incubation mixture contained 0.05 M sodium phosphate buffer 
(pH 7.5), 1.5 mM EDTA, 0.27 M sucrose, and 20 mg microsomal protein in a 
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final volume of 2 ml. In other incubation mixtures, 3 mM NADPH or NADH 
was included. Incubations were performed in the presence of sucrose to 
assist in the solubilization of the steroid hydroperoxides. However, 
similar products were obtained when sucrose was omitted from the incubat-
ion medium although the yield was usually smaller. The reaction was 
initiated by addition of 0.02 ml of a 10 mg/ml ethanolic solution of 
hydroperoxide and the mixture was incubated in air or under nitrogen at 23° 
for 15 minutes. Control incubations without microsomes or steroid substrates 
were carried out. Products were extracted with 20 ml of methylene chloride 
and the suspension filtered through Whatman phase separating (silicone-
treated) filter paper. The extract was concentrated under vacuum, the 
residue transferred with ether to a small tube and the solvent removed under 
nitrogen. The products were redissolved in 0.05 ml methylene chloride and 
0.01 ml was used for tlc analysis. The extracts were applied onto a 20 em 
x 20 em chromatoplate of silica gel HF 254 0.25 mm thick together with 
authentic steroids. The chromatoplate was developed three times with 
benzene-ethyl acetate-acetone (10:1:1) in the case of progesterone 17a-
hydroperoxide metabolites or five times with toluene-ethyl acetate-acetone 
(12:2:1) in the case of pregnenolone 17a-hydroperoxide metabolites. The 
steroids were visualized under 254 nm ultraviolet light or by their color 
response towards 50% sulfuric acid at 110° and steroid hydroperoxides were 
located by spraying with an N,N-dimethyl-£-phenylenediamine solution (91). 
Mobility data (R ) are given in terms of progesterone as unity in the two 
c 
solvent mixtures employed. The recovery of products from the progesterone 
17a-hydroperoxide incubations was 70 - 90%. 
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For analysis of the products by gas chromatography and mass 
spectrometry, incubations were performed on a larger scale (x 10), products 
were extracted with 200 ml methylene chloride and the final residue sus-
pended in 0.5 ml methylene chloride. The sample was applied as a fine 
even line onto a 20 x 20 em chromatoplate which was developed in the usual 
manner. The steroids were located under 254 nm ultraviolet light or by 
spraying a 1 em strip with 50% sulfuric acid followed by gentle heating 
for 2 min. Each steroid zone was scraped off the chromatoplate, the 
steroids were extracted with methylene chloride, each fraction was applied 
onto a separate chromatoplate 5 em x 20 em and again chromatographed and 
recovered in the usual manner. The products were finally identified by 
comparison of their chromatographic and spectral properties with those of 
authentic steroids. 
Gas chromatography was conducted on a Hewlett-Packard 420 gas 
chromatograph using silanized glass U-tubes packed with 3% QF-1 (trifluoro-
propylmethyl silicone) or 3% SE-30 (methyl silicone) on 80 - 100 mesh 
Gas-Chrom Q (93). Injection port temperature was 250°, column temperature 
was 240°, and the carrier gas was nitrogen at a flow rate of 22 ml/min. 
Gas chromatographic retention times (tR) are given in terms of progesterone 
taken as unity. Absolute retention time of progesterone was 10 minutes 
on 3% QF-1 column and 6 minutes on 3% SE-30 column. 
Mass spectral measurements were carried out using an AEI MS-30 
double beam instrument, with heptacosafluorobutylamine in the reference 
beam. Samples were introduced in the sample beam via a membrane separator 
operated at 215° and connected to a Pye Unicam model 104 gas chromat ograph 
equipped with a 6 ft long, 3 mm internal diameter glass column packed with 
3% QF-1 on 80-- 100 mesh Gas Chrom Q, operated at 240° with helium as 
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carrier gas at a flow rate of 30 ml/min. Spectra of resolved steroids 
were obtained at 24 eV with a resolution of 1000 and a scanning speed 
of 10 sec per decade. 
Quantitation of progesterone 17a-hydroperoxide metabolites by fluorescence 
scanning 
Progesterone 17a-hydroperoxide was incubated with microsomal 
fractions and the products were extracted with 20 ml methylene chloride 
and isolated as described above. Thin layer chromatoplates (20 em x 20 em) 
of silica gel HF 254 0.25 mm thick were evenly divided into 20 identical 
zones 1 em x 20 em each. The steroid products from the various incubat-
ions and reference steroids were applied onto the chromatoplate which was 
then developed three times with benzene-ethyl acetate-acetone (10:1:1). 
Each steroid zone was scanned by reflectance at 254 nm against a blank zone 
using a Spectrodensitometer Model SD-3000 (Schoeffel Instruments, Westwood, 
New Jersey) equipped with an SDC 3000 density computer. The percentage of 
each compound formed was calculated from the area of the peaks obtained 
on the scanning trace. This method of quantitation appeared to be reliable 
since the area of the peaks obtained on the scanning trace was directly 
proportional to the amount of steroid applied onto the chromatoplate. 
Incubation of cumene hydroperoxide with microsomal fractions 
A mixture containing 0.05 M sodium phosphate buffer (pH 7.5), 
1.5 mM EDTA, 20 mg microsomal protein, and 0.25 mM cumene hydroperoxide in 
a final volume of 2 ml was incubated at 23° for 20 minutes. Other 
incubations were performed in the presence of 3 mM NADH or NADPH. Control 
incubations without microsomal fraction or hydroperoxide were carried 
out. The reaction mixture was extracted with 20 ml diethyl ether, the 
water layer removed, and the ether extract concentrated. The residue 
was applied onto a 20 em x 20 em plastic strip coated with silica gel 
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N-HR 0.2 mm thick and chromatographed 'three times using a toluene-diethyl 
ether (20:1) solvent system. The products were located by spraying a 
small portion of the strip with 50% sulfuric acid followed by gentle heat-
ing for 2 min. The tlc mobilities and colors were compared with reference 
samples. 
For analysis of the products by gas chromatography, the various 
product zones were scraped off the tlc strip, eluted with diethyl ether 
and identified by gas chromatography by comparison with authentic samples. 
Gas chromatography was conducted on the SE-30 column at an oven temperature 
of 90° and a carrier gas flow rate of 22 ml/min. Retention times are given 
in terms of ethanol taken as unity with an absolute retention time for 
ethanol of 0.7 minutes. 
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RESULTS 
Conversion products of progesterone 17a-hydroperoxide 
Progesterone 17a-hydroperoxide was incubated in air or under 
nitrogen with bovine adrenocortical microsomes in the presence and 
absence of NADPH or NADH. The products were quantitated by fluorescence 
scanning and identified by comparison of their chromatographic and 
spectral properties to those of authentic steroids. 
Incubation of progesterone 17a-hydroperoxide in air with adreno-
cortical microsomes for 15 minutes gave 17a-hydroxyprogesterone (A1 , 58%) 
and androstenedione (B1 , 17%) as the major metabolites together with some 
unconverted hydroperoxide (Table 11). A fluorescence scanning trace of 
the thin layer chromatoplate containing a mixture of these products and a 
mixture of reference steroids is shown in Fig. 7. Replacing the air phase 
by a nitrogen atmosphere did not alter the nature or extent of product 
formation in the incubations (Table 11). 
Incubation of progesterone 17a-hydroperoxide in air with adreno-
cortical microsomal preparations fortified with 3 mM NADPH resulted in the 
formation of three major products: 17a-hydroxyprogesterone (A2 , 33%), 
androstenedione (B2 , 11%), and 17a, 21-dihydroxyprogesterone (C1 , 43%) 
together with a small amount of unconverted hydroperoxide (Table 11). 
A fluorescence scanning trace of a tlc plate containing a mixture of 
these products together with a mixture of authentic steroids is shown in 
Fig. 8. Substitution of NADH for NADPH in the incubation medium also gave 
rise to similar products although less of the 17a, 21-diol was formed 
(Table 11). However, when incubations were carried out in the presence 
TABLE 11 
CONVERSION PRODUCTS OF PROGESTERONE 17a-HYDROPEROXIDE INCUBATED WITH 
ADRENOCORTICAL MICROSOMES UNDER AIR OR NITROGEN a 
Incubation Conditions 
Microsomes 
Microsomes + NADPH 
Microsomes + NADH 
17a-hydroxy-
progesterone 
Air 
58 58 
33 60 
34 61 
Androstenedione 
Air 
17 10 
11 8 
11 9 
% of 
Products Recovered 
17a, 21-dihydroxy-
progesterone 
Air 
0 0 
43 0 
32 0 
Hydroperoxide 
Remaining 
Air 
25 32 
13 32 
23 30 
a Progesterone 17a-hydroperoxide was incubated with adrenocortical microsomes in the presence of 3 mM 
NADPH or NADH. Products were identified by tlc, gas chromatography, mass spectrometry and quantitated 
by fluorescence scanning as described in Materials and Methods. 
lJ1 
lJ1 
Figure 7. Fluorescence scanning trace of products obtained upon incubation of 
progesterone 17a-hydroperoxide with adrenocortical microsomes. 
Progesterone 17a-hydroperoxide was incubated with adrenocortical 
microsomes and the products extracted and chromatographed. The 
chromatoplate containing products and reference steroids was 
scanned by reflectance at 254 nm using a 0 to 0.1 absorbance span 
as described in Materials and Methods. The % of each compound was 
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I: 17a,21-dihydroxyprogesterone; II: 17a-hydroxyprogesterone; 
III: progesterone 17a-hydroperoxide; IV: androstenedione; V: progesterone. 
Figure 8. Fluorescence scanning trace of products obtained upon incubation ' of 
progesterone 17a-hydroperoxide in air with adrenocortical microsomes 
in the presence of 3 rnM NADPH. 
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of NADPH or NADH under a nitrogen atmosphere, only two products 
identified as 17a-hydroxyprogesterone and androstenedione were formed 
and no 17a, 21-diol was detected (Table 11). These results suggest 
that the oxygen atom at the C-21 position of 17a, 21-dihydroxyprogesterone 
was supplied by molecular oxygen by way of an active C-21 hydroxylase (94) 
rather than by a molecular rearrangement of the 17a-hydroperoxy group. 
This conclusion is strengthened by the fact that incubation of 17a-
hydroxyprogesterone in air with adrenocortical microsomal fractions 
supplemented with NADPH or NADH also resulted in the formation of 17a, 21-
dihydroxyprogesterone whereas in the absence of air, diol formation did 
not occur. 
Incubation of progesterone 17a-hydroperoxide in air with rat 
liver microsomes gave rise to two major products again identified as 17a-
hydroxyprogesterone (A3 , 37%) and androstenedione (B 3 , 18%) together with 
at least five more polar and as yet unidentified metabolites. A similar 
spectrum of products was obtained when incubations were carried out under 
a nitrogen atmosphere or when the hydroperoxide was exposed to various 
heme compounds such as cytochrome c or methemoglobin. When incubations 
were performed in the absence of added microsomal fractions, or with a 
previously boiled enzyme preparation, progesterone 17a-hydroperoxide 
remained virtually unchanged. 
Progesterone 17a-hydroperoxide gave an Rc of 0.71 (yellow-brown 
color with sulfuric acid and a positive color reaction with N,N-dimethyl-
p-phenylenediamine reagent);~' characteristic decomposition pattern; ms, 
solid probe, m/e (%)*: 346 (M+, 5), 330 (41), 302 (31), 287 (22), 286 (100), 
* % refers to the relative abundance of the various ions taking the largest 
peak {in tmscase at m/ e 286) as tOO%. 
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269 (27), etc. Total decomposition of the hydroperoxide occurred upon 
injection in the flash heater zone of the g£ system, as evidenced by the 
symmetry of the elution patterns of the various decomposition products on 
both QF-1 and SE-30 columns. Three major thermal decomposition products 
were identified as: (1) androstenedione (B4), (2) progesterone (D1 ), and 
(3) 17a-hydroxyprogesterone (A4). To a fourth major product, eluting on 
both QF-1 and SE-30 just before androstenedione and with mass spectral 
properties similar to androstenedione, we tentatively assign the structure 
of andros~~en-3-one 16, 17-epoxide (E1). 
Table 12 (top section) summarizes the tlc, g£, and ms data of 
the major metabolites of progesterone 17a-hydroperoxide. 
Conversion metabolites of pregnenolone 17a-hydroperoxide 
Decomposition of pregnenolone 17a-hydroperoxide by adrenocortical 
microsomes followed a similar pattern as was observed for its progesterone 
analog. The major product was identified as 17a-hydroxypregnenolone 
(W1 ) and a second product was identified as dehydroepiandrosterone (X1 ). 
When NADPH or NADH was included in the incubation medium again similar 
products were obtained and no C-21 hydroxy derivative was detected, in con-
trast to the result obtained when progesterone 17a-hydroperoxide was 
employed as substrate. It therefore appears that pregnenolone derivatives 
are not hydroxylated at the C-21 position by the C-21 hydroxylase of 
adrenocortical microsomes, as was also demonstrated by Ryan and Engel (94). 
Incubation of the hydroperoxide with liver microsomes again gave 
two major products identified as 17a-hydroxypregnenolone (W2) and dehydro-
epiandrosterone (X2 ) but in addition, several more polar and as yet 
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unidentified products were recovered. No appreciable formation of these 
products occurred when incubations were carried out in the absence of 
microsomal fractions. 
Injection of pregnenolone 17a-hydroperoxide (Rc 0.66, purple-
brown) in the flash heater zone of ~system resulted in total decomposition. 
The products gave a characteristic elution pattern on both QF-1 and SE-30 
columns. The major products were identified as: 1) dehydroepiandrosterone 
(X3), 2) pregnenolone (Y1 ), and 3) 17a-hydroxypregnenolone (W3). To a 
fourth major product we assign the tentative structure of androst-5-en-3S-
ol 16, 17-epoxide (Z 1). 
Table 12 (bottom section) summarizes the tlc, ~ and ms data of 
the major decomposition products of pregnenolone 17a-hydroperoxide. 
Products of decomposition of cumene hydroperoxide 
Cumene hydroperoxide was found to act as a substrate for micro-
somal cytochrome P-450 (74) and it was therefore desirable to obtain data 
on the products formed when the hydroperoxide is exposed to microsomal 
fractions. Cumene hydroperoxide was incubated with liver or adrenocortical 
microsomes in the presence and absence of NADPH or NADH and the products 
were identified by tlc and g£· Only one product was detected in significant 
yield and characterized as 2-phenyl-2-propanol, Rf 0.32 (relative to the sol-
vent front) with toluene-diethyl ether (20:1) as solvent (purple color with 
sulfuric acid); tR 5.6 (ethanol as unity) on the SE-30 column, identical in 
these properties to an authentic sample . No formation of the product was 
noticed in the absence of microsomal fractions. 
TABLE 12 
SUMMARY OF THE THIN LAYER CHROMATOGRAPHIC, GAS CHROMATOGRAPHIC AND MASS SPECTRAL ANALYSIS 
OF PROGESTERONE 17a-HYDROPEROXIDE AND PREGNENOLONE 17a-HYDROPEROXIDE METABOLITES a 
Mass Spectra 
Color with Retention Time (tR) Other Ions R 50% H2so4 + m/e (%)e Products 
__9!:l_ SE-30 M 
Al, A2, A3, A f 0.61b yellow-brown 1.31 1.39 330(83) 312(24)' 302(54) 4 287(100), 269(39) 
B1, B2, B3, Bt+ 
f 0.86b dark green 0.78 0.64 286 (100) 271(10, 245(13) 
cl 0.29b magenta 0.78d 0.64d 346 (30) 316 (64)' 299 (31) 
1.04 1.25 287(100), 269(44) 
1.40 253(20), 244(87) 
Dl l.OOb yellow 1.00 1.00 314(100) 272(96), 244(37) 
El 0.57 0.29 286(100) 287 (21)' 244 (44) 
w1, w2, w f 0.60c magenta 0.39 0.91 352(57) 314(34), 287(29) 3 271(57), 253(100) 
c 
0.78c Xl, X2, X ... purple 0.22 0.41 288(93) 273(12)' 270(92) 3 255(100) 
yl magenta 0.32 o. 78 316 (83) 301(21). 298(100) 
283(75) 
zl 0.16 0.36 288(54) 270(100), 255(80) 
a Hetabolites of the pregnene 17U-hydroperoxides were analyzed as described in text. 
b Benzene-ethyl acetate-acetone (10:1:1) 
c Toluene-ethyl acetate-acetone (12:2:1) 
d Decomposition on .B.£ columns to yield a characteristic fragn1entation pattern 
e % refers to the relative abundance of the various ions taking the largest peak as 100% 
f 1 product obtain~d under different incubation conditions Each letter refers to a particu ar ~ 
as described in the Results section. 
Structure Assigned 
17a-hydroxyprogesterone 
androstenedione 
17a,21-dihydroxypro-
gesterone 
progesterone 
androst-4-en-3-one 16, 
17-epoxide 
17a-hydroxypregnenolone 
dehydroepiandrosterone 
pregnenolone 
androst-5-en-·3S-ol 16, 
17-epoxide 
, ... -.....-__ _ 
Cumene hydroperoxide (Rf 0.61, orange-brown) decomposed in 
the flash heater zone of the~ system (90°), giving a characteristic 
elution pattern of decomposition products on the SE-30 column, tR 14.0 
(major), 2.5 (minor), and 5.6 (minor). 
- 62 -
CHAPTER III 
THE MICROSOMAL NADPH-PEROXIDASE ELECTRON 
TRANSPORT SYSTEM 
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CHAPTER III: THE MICROSOMAL NADPH-PEROXIDASE ELECTRON TRANSPORT SYSTEM 
This chapter will investigate the role of various electron 
transport components in the microsomal NADPH-peroxidase enzyme system. 
MATERIALS AND METHODS 
Materials 
Trypsin, soybean trypsin inhibitor, nucleotides, £-hydroxymercuri-
benzoate, phosphatidylcholine, and lysophosphatidylcholine*were purchased 
from Sigma. £-Chloro-N-methylaniline was obtained from Calbiochem. Phena-
cetin was a product of British Drug Houses, Toronto. 
Assay of NADPH-peroxidase activity 
Microsomal NADPH-peroxidase activity was measured at 23° by 
following the rate of oxidation of NADPH by hydroperoxides in the first min 
of reaction at 340 nm in the presence of microsomal fraction. The assay 
medium contained, unless otherwise stated, 0.067 M sodium phosphate buffer 
(pH 7.5), 0.27 M sucrose, 2 mg microsomal protein, 0.15 mM NADPH, and 0.05 
mM hydroperoxide in a final vol of 3 ml. Reaction rates were routinely 
corrected for NADPH oxidation in the absence of hydroperoxide and were 
1 1 d . ff . f NADPH of 6.22 cm-l mM-l. ca cu ate using an extinct1on coe ic1ent or 
Measurements were normally carried out with a Beckman DB-G double beam 
spectrophotometer. Turbidity in the sample solutions was balanced by using 
a reference cuvette containing 0.067 M sodium phosphate buffer and the same 
* Phosphatidylcholine prepared from egg yolk contained primarily a mixture 
of stearic and palmitic acids; lysophosphatidylcholine prepared by the 
action of phospholipase A on phosphatidylcholine also contained palmitic 
and stearic acids. 
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concentration of microsomal protein as employed in the sample cuvette. 
Reactions which produced low velocities or those which utilized large 
quantities of protein were measured using a Perkin-Elmer 356 dual wave-
length spectrophotometer in the split beam mode. 
Steroid hydroperoxides were dissolved in ethanol just before use 
and 10 microliter amounts were added to the assay medium. Sucrose was 
included in the reaction medium to assist in the solubilization of the 
steroid hydroperoxides. Concentrations of steroid hydroperoxides above 
0.1 mM could not be used since these hydroperoxides came out of aqueous 
solution under the specified assay conditions. 
Determination of the K for NADPH in the NADPH-peroxidase reaction 
m 
An estimate of the K for NADPH in the NADPH-peroxidase reaction 
m 
was made by following the rate of oxidation of NADPH at 340 nm on a 
Perkin-Elmer 356 recording spectrophotometer, with a full-scale deflection 
of 0.1 absorbance units. The assay medium contained 0.1 M sodium phosphate 
buffer (pH 7.5), 0.17 mg liver microsomal protein, varying amounts of NADPH, 
and 0.8 mM cumene hydroperoxide in a final vol of 3 ml. Reaction rates 
were corrected for NADPH oxidation in the absence of cumene hydroperoxide. 
Enzyme assays 
The microsomal N-demethylation of p-chloro-N-methylaniline was 
determined essentially by the method of Kupfer and Bruggeman (95). NADPH-
or NADH-cytochrome £ reductase activity was measured at 23° by following 
the reduction of cytochrome £ (50 ~M) at 550 nm in a 3 ml solution contain-
ing 0.033 M sodium phosphate buffer (pH 7.5), 0.15 mM NADPH or NADH, and a 
suitable amount of microsomal protein. An extinction coefficient 
-1 -1 between reduced and oxidized cytochrome c of 21 em mM (96) was 
employed in the calculation of the reaction rates. 
Preparation of antibodies 
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Antiserum to NADPH-cytochrome £ reductase prepared from rabbits 
by the method of Glazer et al (31) was kindly supplied by Professor J.B. 
Schenkman, Yale University. Antibody to cytochrome b 5 prepared by the 
procedure of Fukushima et al (97) was kindly donated by Professor T. Omura, 
Kyushu University. 
Preparation of microsomal lipid 
Lipid was prepared from rat liver microsomes by DEAE-cellulose 
chromatography of a deoxycholate-solubilized extract followed by extraction 
with chloroform-methanol according to Strobel et al (56) up to the silicic 
acid chromatography step. The organic solvent mixture was removed under 
reduced pressure and the microsomal lipid stored anaerobically at -5°. 
Solubilization of lipids 
Microsomal lipid was solubilized by sonic oscillation at 4° under 
a nitrogen atmosphere in 0.01 M Tris-acetate buffer (pH 8.0) containing 
0.1 mM EDTA. The lipid was suspended to a concentration of 5 mg/ml and 
sonicated at 20 sec intervals for 2 min or until the solution turned clear. 
Phosphatidylcholine, lysophosphatidylcholine, and phosphatidylcholine-
lysophosphatidylcholine micelles were prepared by a similar procedure. 
Preparation of various microsomal constituents for reconstitution of 
NADPH-peroxidase activity 
- 67 -
Purified NADPH-cytochrome ~ reductase was prepared from rat 
liver microsomes by trypsin solubilization following the procedure of 
Omura and Takesue (98) and by deoxycholate solubilization according to 
Lu et al (23). Cytochrome E5 was prepared from rat liver microsomes 
by trypsin digestion according to Omura and Takesue (98) and by detergent 
solubilization as described by Spatz and Strittmatter (99). Partially 
purified cytochrome P-450 was prepared by cholate solubilization of liver 
microsomes according to Lu et al (23). 
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RESULTS 
The NADPH-peroxidase assay 
The NADPH-peroxidase reaction was measured by following the 
rate of oxidation of NADPH by hydroperoxides at 340 nm in the presence 
of microsomal fractions. It was found that hydroperoxides can markedly 
enhance the rate of NADPH oxidation by microsomes. Using cumene hydro-
peroxide as substrate and rat liver microsomes as the enzyme source, the 
reaction rate was found to be first-order with respect to microsomal pro-
tein concentration (Fig. 9). Using cumene hydroperoxide as substrate, 
the reaction rate showed saturation kinetics with increasing concentrations 
of hydroperoxide and an apparent K of about 0.4 mM was obtained*(Fig. 10). 
m 
Under these assay conditions, the rate of NADPH oxidation was calculated 
to be approximately 28 nmoles/min/mg protein/~mole cumene hydroperoxide.* 
An estimate of the K for NADPH in the NADPH-dependent peroxidase 
m 
reaction was made by following the course of oxidation of the reduced 
nucleotide on a recording spectrophotometer with a full-scale deflection 
of 0.1 absorbance units as described in Methods. It was found that an 
NADPH concentration of 6 ~M gave an identical initial reaction rate (27 
nmoles of NADPH oxidized/min/mg protein/ ~mole cumene hydroperoxide) to that 
obtained when higher amounts of NADPH were employed. It appears, therefore, 
that the K for NADPH in the reaction is smaller than 3 ~M. A more precise 
m 
measurement of the K using this technique could not be obtained. 
m 
Hydroperoxide specificity of microsomal NADPH-peroxidase 
A comparison of the effectiveness of various hydroperoxides in 
oxidizing NADPH in the presence of liver or adrenocortical microsomes is 
* A similar K value was also obtained using a Lineweaver-Burke plot. 
m 
** Under these assay conditions~ the reaction rate was first-order with 
respect to microsomal protein concentration and first-order with respect 
+.n r>vmP-nP- hvdr>nnP.r>n.r.?:dP. cnncP.ntration. 
Figure 9. Effect of increasing microsomal ·protein concentration on 
NADPH-peroxidase activity. 
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The reaction was measured at 340 nm in a 3 ml system containing 
0.067 M sodium phosphate buffer (pH 7.5), 0.15 mM NADPH, liver 
microsomal protein, and 0.4 mM cumene hydroperoxide. 
Figure 10. Effect of increasing cumene hydroperoxide concentration on 
microsomal NADPH-peroxidase activity. 
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The assay medium contained 0.067 M sodium phosphate buffer (pH 7.5), 0.15mM NADPH, 
0.9 mg liver microsomal protein, and varying amounts of hydroperoxide in a final volume 
of 3 ml. Reaction rates were corrected for NADPH oxidation in the absence of hydro-
peroxide. 
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presented in Table 13. It is noticed that the 17a-hydroperoxide deriva-
tives of progesterone and pregnenolone were effective substrates for the 
microsomal enzyme system of both liver and adrenal cortex. 
Tissue distribution of microsomal NADPH-peroxidase activity 
In Table 14 is shown the tissue distribution of the microsomal 
NADPH-peroxidase activity. It is seen that the microsomal fractions from 
tissues which contained high amounts of cytochrome P-450 per milligram 
protein (e.g. liver, adrenal cortex) were the most active in catalyzing 
the NADPH-peroxidase reaction whereas microsomes from tissues that contained 
little or no cytochrome P-450 showed either weak activity or no activity at 
all. However, a perusal of the data shows that the reaction rates were not 
strictly proportional to cytochrome P-450 content. 
The properties of the NADPH-peroxidase enzyme system of rat liver 
microsomes were next investigated in detail. 
Efficiency of NADPH oxidation by hydroperoxides 
Examination of the stoichiometry of the NADPH-peroxidase reaction 
revealed the oxidation of approximately 0.35 moles of NADPH per mole of 
cumene hydroperoxide in the presence of liver microsomes under the normal 
assay conditions. Since NADPH has two reducing equivalents and cumene 
hydroperoxide has two oxidizing equivalents, this represents a 35% 
efficiency and indicates a competition between NADPH and certain microsomal 
constituents for the oxidizing equivalents of the hydroperoxide. Hydrogen 
donors other than NADPH have been found to be oxidized by hydroperoxides 
at a similar efficiency in the presence of various heme catalysts (100-
102). 
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TABLE 13 
EFFECTIVENESS OF VARIOUS HYDROPEROXIDES IN OXIDIZING NADPH IN THE 
PRESENCE OF MICROSOMAL FRACTIONS a 
Hydroperoxide 
Progesterone 17a-hydroperoxide 
Pregnenolone 17a-hydroperoxide 
Cumene hydroperoxide 
Cholesterol 76-hydroperoxide 
Allopregnanolone 17a-hydroperoxide 
NADPH-Peroxidase activity a 
Liver 
microsomes 
6.7 
5.8 
4.8 
4.3 
2.9 
Adrenocortical 
microsomes 
1.0 
0.7 
0.7 
a The oxidation of NADPH by hydroperoxides in the presence of microsomal 
fractions was measured at 340 nm as described in Methods. Reaction 
rates are expressed as nmoles NADPH oxidized/min/mg protein. The cone. 
of hydroperoxide used in the assay was 0.05 mM. 
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TABLE 14 
TISSUE DISTRIBUTION OF MICROSOMAL NADPH-PEROXIDASE ACTIVITY a 
NADPH-Peroxidase 
Source of Microsomes P-450 Content Activity 
liver 0.70 48.4 
adrenal cortex b 0.60 9.7 
lung 0.05 3.9 
kidney 0.25 2.0 
testis 0.02 0.3 
small intestine 0.02 0 
brain 0 0 
heart 0 0 
skeletal muscle c 0 0 
~icrosomes from various tissues of the rat were prepared and the P-450 
content measured as described in Methods. NADPH-peroxidase activity 
was determined at 340 nm in a 3 ml system containing 0.067 M sodium 
phosphate buffer (pH 7.5), 0.15 mM NADPH, 1 mg microsomal protein, and 
0.8 mM cumene hydroperoxide. Reaction rates were corrected for NADPH 
oxidation in the absence of hydroperoxide and are expressed as nmoles 
NADPH oxidized/min/mg protein. P-450 content is expressed as nmoles/ 
mg protein. 
bAdrenal cortex microsomes were obtained from bovine adrenals. 
cThe hind legs of the rat were used for the source of skeletal muscle. 
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Inhibition of NADPH-peroxidase activity by various reagents 
The effect of various inhibitors on the microsomal oxidation 
of NADPH by cumene hydroperoxide was next investigated. Cumene hydro-
peroxide was chosen as the model substrate because its solubility in 
aqueous medium is sufficient (84) to permit inhibitor studies of the 
reaction. It was found that the enzyme system was heat labile, being 
totally inactivated by preincubation of liver microsomes at 80° for 
5 minutes (Table 15). Measurement of the activity under a nitrogen or a 
carbon monoxide atmosphere produced no appreciable inhibition of the 
reaction rate. + NAD produced a weak inhibition whereas 2-phenyl-2-
propanol, the hydroxy derivative and main decomposition product of cumene 
hydroperoxide, exhibited no appreciable effect. Acetone and tert. amyl 
alcohol, reagents that are known to convert cytochrome P-450 to its 
inactive P-420 form (103), were potent inhibitors of the reaction. 
Evidence for the involvement of NADPH-cytochrome c reductase in NADPH-
peroxidase activity 
Fig. 11 illustrates the pH dependence of the NADPH-peroxidase 
activity in 0.1 M sodium phosphate buffer. A pH optimum forilie activity 
of about 8.2 was obtained which was similar to the pH optimum reported 
by Williams and Kamin (29) for microsomal NADPH-cytochrome £ reductase 
activity. 
In Fig. 12 is shown the effect of ionic strength on the micro-
somal NADPH-peroxidase reaction. It is observed that the activity was 
stimulated by increasing concentrations of sodium phosphate buffer. 
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TABLE 15 
EFFECT OF VARIOUS INHIBITORS ON NADPH-PEROXIDASE ACTIVITY a 
Inhibitor % Inhibition 
Heat (80° for 5 min) 100 
N. b 1trogen 9 
c Carbon Monoxide 10 
NAD+ (0.45 mM) 20 
2-Phenyl-2-propanol (0.4 mM) 6 
Acetone (5%) 73 
tert. Amyl alcohol (7%) 82 
a 0 NADPH-peroxidase activity was measured at 23 by following the 
oxidation of NADPH at 340 nm in a 3 ml solution containing 0.067 M 
sodium phosphate buffer (pH 7.5), 0.15 mM NADPH, 1 mg liver micro-
somal protein, specified amounts of various inhibitors, and 0.4 mM 
cumene hydroperoxide. Reaction rates were corrected for NADPH 
oxidation in the absence of hydroperoxide. The specific activity of 
the NADPH system in the absence of inhibitor, in terms of nmoles 
NADPH oxidized/min/mg protein, was 34. 
b The contents of an anaerobic cuvette were gassed with N2 (99.99% pure) for 5 min prior to mixing with hydroperoxide. 
c The contents of an anaerobic cuvette were gassed with N2 for 10 min 
and with CO that had been passed through a deoxygenating medium (83) 
for 5 min prior to addition of cumene hydroperoxide. 
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Figure 11. The pH dependence of the microsomal NADPH-peroxidase 
reaction. 
The assay medium contained 0.1 M sodium phosphate buffer 
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of varying pH, 0.15 mM NADPH, 1 mg liver microsomal protein, 
and 0.4 mM cumene hydroperoxide in a final volume of 3 ml. 
The pH was routinely checked at the end of the reaction. 
oLi6----------~7L---------~8----------~g~-­
pH 
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Figure 12. Effect of ionic strength on microsomal NADPH-peroxidase 
activity. 
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The reaction medium consisted of 0.067 M sodium phosphate 
buffer (pH 7.5), 0.15 mM NADPH, 1 mg liver microsomal protein, 
and 0.4 mM cumene hydrope~oxide tD which increasing amounts 
of KCl or additional phosphate was added to obtain desired 
ionic strengths. Final ionic strength was calculated from the 
concentrations of phosphate and added KCl. 
0.25 0.50 0.75 1.00 
IONIC STRENGTH 
KCl exhibited an equal stimulatory effect when tested at the same ionic 
strengths as phosphate. The activity of microsomal NADPH-cytochrome £ 
reductase has also been reported to be stimulated by increasing concen-
trations of phosphate or KCl (96). 
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The activity of NADPH-cytochrome c reductase is markedly inhibited 
by NADP+ and by low concentrations of sulfhydryl reagents such as £-hydroxy-
mercuribenzoate (29, 96). Preincubation of the flavoenzyme with NADPH 
prior to treatment with £-hydroxymercuribenzoate partially protects the 
flavoprotein from inactivation. Our results (Table 16) show that micro-
somal NADPH-peroxidase activity was markedly inhibited by 0.05 mM £-
hydroxymercuribenzoate and preincubation of microsomes with NADPH prior to 
addition of sulfhydryl inhibitor partially protected the enzyme system from 
inactivation. NADP+ was also found to be an inhibitor of the NADPH-
peroxidase reaction. 
Antiserum prepared to NADPH-cytochrome c reductase was next used 
to evaluate further the role of the flavoprotein reductase in the microsomal 
NADPH-peroxidase reaction. The results (Fig. 13) demonstrate a striking 
similarity in the pattern of inactivation of NADPH-cytochrome c reductase 
and NADPH-peroxidase activity by the antiserum. On the other hand, NADH-
cytochrome £reductase activity was not affected by the treatment. 
Furthermore, the antiserum did not inhibit the TMPD-peroxidase reaction, 
a cytochrome P-450-dependent activity which is assayed by following the 
P-450-catalyzed rate of oxidation of TMPD by hydroperoxide. It, therefore, 
appears that the antiserum was a fairly specific inhibitor of NADPH-
cytochrome c reductase (31). 
TABLE 16 
INHIBITION OF NADPH-PEROXIDASE ACTIVITY BY INHIBITORS 
OF NADPH-CYTOCHROME c REDUCTASE a 
Inhibitor % Inhibition 
~-Hydroxymercuribenzoate b (0.05 mM) 80 
c ~-Hydroxymercuribenzoate after NADPH 35 
NADP+ (0.60 mM) 35 
a 
b 
c 
NADPH-peroxidase activity was measured in the presence of specified 
amounts of inhibitors as described in Table 15. 
~-Hydroxymercuribenzoate (0.05 mM) was incubated with 1 mg liver 
microsomal protein in 0.067 M sodium phosphate buffer (pH 7.5) for 
2 min directly in the assay cuvette. After incubation, NADPH 
(0.15 mM) and cumene hydroperoxide (0.4 mM) were added and activity 
determined in a final vol of 3 ml. 
NADPH was incubated with liver microsomes for 1 min prior to addit-
ion of ~-hydroxymercuribenzoate and hydroperoxide. 
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Figure 13. Concomitant inhibition of microsomal NADPH-cytochrome £reductase 
and NADPH-peroxidase activity by antiserum to NADPH-cytochrome £ 
reductase. 
Liver microsomes were incubated with indicated amounts of antiserum 
at 23° for 5 minutes directly in the assay cuvette in a 1 ml solution 
containing 0.1 M sodium phosphate buffer (pH 7.5). After incubation 
the rest of the assay components were added to make up a total volume 
of 3 ml. For the measurement of NADPH-peroxidase activity, 1 mg 
microsomal protein and 0.5 mM cumene hydroperoxide was used and for 
the NADH- and NADPH-cytochrome c reductase activities, 0.05 mg and 
0.30 mg microsomal protein, respectively,was employed. The specific 
activity in the absence of antiserum of the NADPH-peroxidase system 
expressed as nmoles NADPH oxidized/min/mg protein was 58 and of the 
NADH- and NADPH-cytochrome c reductase systems, in terms of nmoles 
cytochrome£ reduced/min/mg-protein, w~s 1570 and 89, respectively. 
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These studies strongly suggest the involvement of NADPH-
cytochrome ~ reductase as one of the electron carriers in the microsomal 
NADPH-peroxidase enzyme system. 
Inhibition of NADPH-peroxidase activity by modifiers of cytochrome P-450 
Compounds termed type I, type II, and modified type II substrates 
interact with microsomal cytochrome P-450 to produce characteristic differ-
ence spectra (34, 35). The NADPH-peroxidase enzyme system was found to be 
sensitive to inhibition by these compounds (Table 17). Steroids that 
form type I spectra with cytochrome P-450 were found to be effective in-
hibitors. The type II ligands such as n-octylamine, imidazole, aniline and 
the modified type II ligands such as corticosterone, phenacetin, and cyanide 
also produced a strong inhibition. 
In Table 18 is shown the effect of various reagents that convert 
cytochrome P-450 to cytochrome P-420 on microsomal NADPH-peroxidase activity. 
It is seen that reagents which effected the conversion of cytochrome P-450 
to cytochrome P-420 (e.g., detergents, protein denaturants, alcohols) also 
produced an inactivation of NADPH-peroxidase activity. Detergents such as 
sodium dodecyl sulfate, sodium deoxycholate, and sodium cholate did not 
inhibit the activity of the flavoenzyme NADPH-cytochrome ~ reductase which 
suggests that the inactivation of NADPH-peroxidase activity by these 
reagents occurs as a result of themnversion of cytochrome P-450 to its 
inactive P-420 form and not as a result of the denaturation of the flavo-
protein reductase. On the other hand, lubrol WX, urea, and n-propanol in 
addition to causing the conversion of cytochrome P-450 to cytochrome P-420 
also inhibited the activity of NADPH-cytochrome c reductase which suggests 
TABLE 17 
INHIBITION OF NADPH-PEROXIDASE ACTIVITY BY TYPE I AND TYPE II SUBSTRATES a 
% % Modified % 
Type I Substrate Inhibition Type II Substrate Inhibition Type II Substrate Inhibition 
Androstenedione (0.1 mM) 70 n-Octy1amine (0.6 mM) 73 Corticosterone (0.1 mM) 
Testosterone (0.1 mM) 68 Aniline (5 mM) 66 Phenacetin (1 mM) 
17S-Estradiol (0.1 mM) 55 Imidazole (2 mM) 66 Potassium cyanide (1 mM) 
Aminopyrine (5 mM) 55 Pyridine (5 mM) 49 
a NADPH-peroxidase activity was measured in the presence of specified cone of type I and type II substrates as 
described in Table 15. 
56 
50 
40 
(X) 
N 
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TABLE 18 
INHIBITION OF NADPH-PEROXIDASE ACTIVITY BY REAGENTS THAT CONVERT 
CYTOCHROME P-450 TO P-420 a 
% Inhibition 
NADPH-
NADPH- cytochrome c % 
-
P-450 Modifier peroxidase reductase P-420 formed 
None 0 0 0 
Sodium dodecyl sulfate (0 .1%) 94 9 98 
Sodium deoxycholate (0. 5%) 80 9 90 
Sodium cholate (1%) 64 9 50 
Lubrol wx (1%) 73 29 40 
Urea (4 M) 40 48 55 
n-Propanol (15%) 97 90 100 
a Liver microsomes (5 mg protein/ml) were incubated at 23° for 20 min 
with specified amounts of P-450 modifier in 0.1 M sodium phosphate buffer 
(pH 7.4) containing 0.4 mM EDTA and 0.05 M sucrose in a final vol of 3 ml. 
After incubation NADPH-peroxidase and NADPH-cytochrome c reductase activi-
ties were measured and the extent of conversion of P-450 to P-420 determined. 
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that part of the inhibition of the NADPH-peroxidase reaction by these 
reagents may be due to the inactivation of the flavoprotein reductase. 
The inhibition of NADPH-peroxidase activity by various P-450 
modifiers suggests the participation of cytochrome P-450 in the reaction. 
Inhibition of NADPH-peroxidase activity by cyanide 
Cyanide is a modified type II ligand which interacts with cyto-
chrome P-450 to produce a characteristic difference spectrum (34, 35, 57). 
In addition, cyanide has been reported to inhibit the P-450- dependent 
hydroxylation of drugs (11) and the demethylation of sterols (57-59) in 
liver microsomes, the c21 hydroxylation of steroids in adrenocortical 
microsomes (94) and the liS-hydroxylation of deoxycorticosterone in adreno-
cortical mitochondria (12). On the other hand, Orrenius (104) found no 
inhibition by cyanide of aminopyrine demethylation in liver microsomes. 
Our results (Fig. 14) demonstrate a 50 percent inhibition of the 
NADPH-peroxidase reaction at a cyanide concentration of about 2.2 mM. This 
value correlates very well with the spectral dissociation constant reported 
for cyanide (K = 2.1 mM) in liver microsomes by Schenkman et al (34). 
s --
Inhibition of microsomal N-demethylase and NADPH-peroxidase activity by 
steroids 
A microsomal electron transport system composed of NADPH-cytochrome 
c reductase and cytochrome P-450 functions in the hydroxylation and demethyl-
ation of a wide variety of lipid-soluble compounds. Our results suggest 
that a similar enzyme system is involved in microsomal NADPH-peroxidase 
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Figure 14. Cyanide inhibition curve for microsomal NADPH-peroxidase 
activity. 
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The NADPH-peroxidase reaction was measured in a 3 ml reaction 
volume containing 0.067 M sodium phosphate buffer (pH 7.5), 
0.15 -mM NADPH, 1 mg liver microsomal protein, varying concen- · 
trations of potassium cyanide, and 0.4 mM cumene hydroperoxide. 
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activity. Steroids are among the physiologically active compounds 
that inhibit microsomal hydroxylation and demethylation reactions and it 
was therefore of interest to determine the effects of several steroids on 
the microsomal N-demethylation of ~-chloro-N-methylaniline and to see if 
similar effects are produced when these steroids interact with the micro-
somal NADPH-peroxidase enzyme system. The results (Table 19) show that 
the same concentrations of steroids used to inactivate drug demethylation 
activity produced similar inhibition of NADPH-peroxidase activity. 
Cytochrome b 5 and microsomal NADPH-peroxidase activity 
Because of the recent suggestion (32) that cytochrome b 5 may 
play a role in NADPH-dependent hydroxylation reactions, the role of cyto-
chrome b 5 in the NADPH-peroxidase reaction was investigated with the aid 
of antibodies prepared to the hemoprotein. Preincubation of liver micro-
somes with 8 mg antibody per mg protein for 5 minutes and subsequent 
measurement of NADPH-peroxidase activity revealed no inhibition of the 
reaction rate. On the other hand, NADH-cytochrome c reductase activity, 
a cytochrome b 5 -dependent function, was inhibited 60% at the same antibody: 
protein ratio. These results argue against the participation of cytochrome 
~ 
b 5 in the microsomal NADPH-peroxidase reaction. Omura (41) recently reported 
no inhibition by antibody to cytochrome b5 of aniline or aminopyrine hydroxy-
lation in liver microsomes. 
Synergistic effect of NADH on the NADPH-peroxidase reaction rate 
Hildebrandt and Estabrook (32) reported the enhancement of NADPH-
dependent microsomal hydroxylation reactions by NADH. Therefore, the effect 
of NADH on the NADPH-dependent peroxidase reaction was investigated. The 
* Work cited in reference 41. 
TABLE 19 
INHIBITION OF MICROSOMAL N-DEMETHYLASE AND NADPH-PEROXIDASE 
ACTIVITY BY STEROIDS a 
% Inhibition 
Steroid Inhibitor N-demethylase NADPH-peroxidase 
Androstenedione 60 67 
Progesterone 59 69 
17a-hydroxyprogesterone 57 57 
Deoxycorticosterone 55 61 
Testosterone 50 68 
Corticosterone 40 56 
a The microsomal N-demethy1ation of £-chloro-N~ethylaniline was 
measured in the presence of 0.1 mM steroid inhibitor by the method 
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of Kupfer and Bruggeman (95). NADPH-peroxidase activity was assayed 
in the presence of 0.1 mM steroid inhibitor as described in Table 15. 
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results (Table 20) demonstrate that NADH can support NADPH-dependent 
peroxidase activity synergistically. In addition, NADH itself can act as 
an efficient electron donor for the microsomal peroxidase reaction. The 
properties of the NADH-peroxidase electron transport system of liver 
microsomes will be described in detail in the next chapter. 
Inhibition of NADPH-peroxidase activity by trypsin 
Previous studies (38) have shown that treatment of liver micro-
somes with trypsin solubilizes NADPH-cytochrome c reductase from the 
microsomal membrane resulting in an inactivation of drug hydroxylation 
activity. In Table 21 is illustrated the effect of trypsin digestion of 
liver microsomes on NADPH-peroxidase activity and other microsomal constit-
uents. It is noticed that incubation of liver microsomes with 25 ~g 
trypsin/mg protein at 10° for 15 hr enhanced NADPH-cytochrome £ reductase 
activity by 25% but inhibited the NADPH-peroxidase reaction by 70%. Since 
trypsin digestion of microsomes converted only 38% of microsomal hemoprotein 
P-450 into the inactive P-420 form, the conversion to P-420 alone cannot 
account for the marked inhibition of the activity. The trypsin treatment 
solubilized 95% of the NADPH-cytochrome £ reductase activity and it seems 
quite probable that part of the inhibition of NADPH-peroxidase activity may 
be due to the release of the flavoprotein reductase from the microsomal 
membrane. Approximately 50% of the total microsomal protein was solubilized 
by the trypsin treatment. 
The residual NADPH-peroxidase activity was recovered mainly in 
the pellet fraction (73%) after centrifugation of the trypsin digest and cyto-
chrome P-450 showed a similar pattern of distribution. In contrast, cytochrome 
b 5 was recovered almost exclusively in the supernatant fraction. The 
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TABLE 20 
SYNERGISTIC EFFECT OF NADH ON THE NADPH-PEROXIDASE REACTION RATE a 
Addition Activity 
Microsomes + NADPH + cumene hydroperoxide 34 
Microsomes + NADH + cumene hydroperoxide 43 
Microsomes + NADPH + NADH + cumene hydroperoxide b 52 
a 
b 
NAD(P)H-peroxidase activity was measured in a 3 ml reaction val con-
taining 0.067 M sodium phosphate buffer (pH 7.5), 0.15 mM NADPH or 
NADH, 1 mg liver microsomal protein, and 0.4 mM cumene hydroperoxide. 
Reaction rates are expressed as nmoles NAD(P)H oxidized/min/mg protein. 
In the assay medium, 0.075 mM of each nucleotide was used to make up a 
total nucleotide cone of 0.15 mM. 
TABLE 21 
EFFECT OF TRYPSIN DIGESTION OF LIVER MICROSOMES ON NADPH-PEROXIDASE ACTIVITY AND OTHER MICROSOMAL CONSTITUENTS a 
NADPH-Cyt. c Cyt. P-450 Cyt. P-420 Cyt. b5 -NADPH-Peroxidase Reductase 
Microsomal Specific Percent Specific Percent Specific Percent Specific Specific Percent 
Preparation activity recovery activity recovery activity recovery activity activity recovery 
Liver microsomes 34 58 0.79 0.03 0.57 
Trypsin-treatedb 
microsomes 11 71 0.45 0.28 0.50 
Supernatant 4 27 119 95 0.15 18 0.29 0.73 95 
Pellet 11 73 6 5 0.68 82 0.19 0.04 5 
aLiver microsomes (10 mg protein/ml) were incubated at 10° with 25 ~g trypsin/mg protein for 15 hr in 0.05 M sodium phosphate 
buffer (pH 7.4) containing 0.3 M sucrose and 2 mM EDTA. Reaction was stopped by addition of trypsin inhibitor (1 mg/mg 
trypsin). The digest was spun at 105,000 a for 2 hr, pellet was suspended in 0.3 M sucrose-2mM EDTA (pH 7.4) and enzymes 
of various fractions were assayed. NADPH-peroxidase activity was measured using 0.4 mM cumene hydroperoxide. NADPH-
peroxidase and NADPH-cyt. c reductase activities are expressed in terms of nmoles NADPH oxidized/min/mg protein, and nmoles 
cyt. ~ reduced/min/mg protein, respectively, whereas cytochrome contents are given in terms of nmoles/mg protein. Percent 
recoveries in the supernatant and pellet fractions were calculated by taking the activities in the trypsin digest as 100%. 
Values are expressed as percent of residual activity recoverable. Actual total recoveries were greater than 90%. 
bT . d . f rypsln-treate m1crosomes re ers to a mixture of soluble and particulate materials obtained after treatment of liver 
microsomes with trypsin as described above. 
1..0 
0 
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presence of a weak NADPH-cytochrome £ reductase activity in the pellet 
fraction was sufficient for the catalysis of a slow NADPH-peroxidase 
activity in the presence of cytochrome P-450 (Table 21). Addition to 
the pellet fraction of purified NADPH-cytochrome £reductase, prepared 
by trypsin digestion of liver microsomes (98), did not increase there-
action rate. 
Reconstitution of the microsomal NADPH-peroxidase activity 
Since the results in this chapter have implicated NADPH-cyto-
chrome c reductase and cytochrome P-450 as electron carriers in the 
microsomal NADPH-peroxidase reaction, a study was undertaken to determine 
whether the membrane-bound enzyme system could be solubilized, resolved 
into its component parts, and reconstituted. Purified NADPH-cytochrome 
£ reductase was prepared by trypsin digestion of liver microsomes follow-
ing the procedure of Omura and Takesue (98). The purified preparation 
catalyzed the reduction of 3.7 ~moles cytochrome £/min/mg protein and was 
free from contamination by other microsomal electron transfer components. 
Partially purified cytochrome P-450 was prepared from livers of normal 
rats by cholate solubilization according to the method of Lu et al (23). 
The final preparation contained 0.56 nmoles P-450 per mg protein. 
The effect on NADPH-peroxidase activity of varying the concen-
tration of purified NADPH-cytochrome £ reductase and cytochrome P-450 is 
shown in Fig. 15. The results indicate that the reaction rate was pro-
portional to the concentration of cytochrome P-450 under conditions where 
NADPH-cytochrome c reductase was present in excess. On the .other hand, 
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Figure 15. Effect of increasing concentrations of purified NADPH-
cytochrome c reductase and cytochrome P-450 on NADPH-
peroxidase activity. 
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The reaction medium consisted of 0.067 M sodium phosphate 
buffer (pH 7.5), 0.15 mM NADPH, varying concentrations of 
purified NADPH-cytochrome c reductase or cytochrome P-450, 
and 0. 8 mM cumene hydroperoxide in a final volume of 3 ml. 
When the concentration of reductase was varied, 0.2 ~M 
P-450 was used and when the concentration of P-450 was 
varied, 75 ~g reductase (specific activity, 3.7 ~moles 
cytochrome ~ reduced/min/mg protein) was employed. Reaction 
rates were corrected for NADPH oxidation in the absence of 
reductase or P-450, respectively. 
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when the concentration of purified NADPH-cytochrome ~ reductase was 
varied in the presence of 0.2 ~M cytochrome P-450, the reaction rate 
although small showed saturation kinetics with increasing amounts of 
flavoenzyme. Similar kinetics were obtained when detergent-solubilized 
NADPH-cytochrome ~reductase, prepared by the method of Lu et al (23l 
was substituted for trypsin-solubilized reductase. However, the cyto-
chrome P-450 preparation was impure and contained a significant amount 
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of NADPH-cytochrome ~ reductase activity (10 nmoles cytochrome £reduced/ 
min/mg protein). Therefore, more efficient reconstitution of NADPH-
peroxidase activity must await further purification of hemoprotein P-450. 
A comparison of the effectiveness of liver microsomes and the 
reconstituted enzyme systemin catalyzing the NADPH-peroxidase reaction 
is shown in Table 22. The specific activity of the reconstituted enzyme 
system using either trypsin-solubilized or detergent-solubilized reductase 
was about 25% of that originally present in liver microsomes. Addition to 
the reconstituted system of either trypsin-solubilized or detergent-
solubilized cytochrome~ (0.2 ~M) did not increasefue reaction rate. 
Lu and coworkers (23., 52) have resolved the liver microsomal 
hydro~ylating enzyme system into fractions containing cytochrome P-450, 
NADPH-cytochrome ~reductase, and lipid. The active lipid component has 
been identified as phosphatidylcholine (56). The effect of microsomal lipid 
or phosphatidylcholine on the NADPH-peroxidase activity of the reconstituted 
enzyme system is presented in Table 22. The results indicate a slight 
increase in the reaction rate after addition of 0.05 mg of microsomal lipid 
or phosphatidylcholine. Addition of larger amounts of lipid did not increase 
the activity any further. 
TABLE 22 
A COMPARISON OF NADPH-PEROXIDASE ACTIVITY IN LIVER MICROSOMES 
AND THE RECONSTITUTED ENZYME SYSTEM a 
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Addition NADPH-Peroxidase Activity 
Liver microsomes 79 
Detergent-solubilized NADPH-cyt. c 
reductase + P-450 18 
Detergent-solubilized NADPH-cyt. c 
reductase+ P-450 + 0.05 mg 
microsomal lipidb 20 
Detergent-solubilized NADPH-cyt. c 
reductase+ P-450 + 0.05 mg 
phosphatidylcholineb 20 
Trypsin-solubilized NADPH-cyt. c 
a 
b 
reductase + P-450 18 
NADPH-peroxidase activity in liver microsomes was measured at 340 nm 
in a 3 ml system containing 0.067 M sodium phosphate buffer (pH 7.5), 
0.15 mM NADPH, 1 mg microsomal protein, and 0.8 mM cumene hydroperoxide. 
The reaction medium for the reconstituted system was identical except 
that 0.5 ~M purified P-450 plus an excess of either detergent-solubilized 
or trypsin-solubilized NADPH-cyt. c reductase were substituted for liver 
microsomes. The effect of lipid on the reaction rate was tested by pre-
incubation of lipid with the reductase and P-450 for 5 min prior to 
assay. Reaction rates are expressed in terms of nmoles NADPH oxidized/ 
min/nmole P-450. 
Microsomal lipid prepared by the method of Lu et al (23) and phospha-
tidylcholine (Sigma) were solubilized by sonication (see Methods) and 
added as an aqueous solution. 
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Stimulation of NADPH-peroxidase activity by phenobarbitaltreatment 
Phenobarbital treatment of rats has been shown to markedly 
increase drug hydroxylation activity and the specific content of cyto-
chrome P-450 in liver microsomes without appreciably affecting the con-
centration of cytochrome b . The effect of phenobarbital pretreatment 
-s 
of rats on microsomal NADPH-peroxidase activity and other components 
of liver microsomes is illustrated in Table 23. It is noticed that the 
specific activity of the NADPH-peroxidase enzyme system was enhanced 
7.5-fold when cumene hydroperoxide was employed as substrate and 2.7-fold 
when progesterone 17a-hydroperoxide was used as substrate. This 
activation was accompanied by a 2.3-fold enhancement of NADPH-cytochrome 
~ reductase activity and a 3-fold increase in cytochrome P-450 concen-
tration. The specific content of cytochrome b 5 showed only a 30% increase. 
Oxidation of NADPH-reduced cytochrome P-450 by hydroperoxides 
Since our results have implicated cytochrome P-450 as an 
electron transfer component in the microsomal NADPH-peroxidase reaction, 
it was of considerable interest to determine whether the reduced form of 
the hemoprotein could be oxidized by hydroperoxides. It was necessary to 
carry out reduction experiments in the absence of oxygen since the 
reduced form of cytochrome P-450 in the microsomal membrane is highly 
autoxidizable. Accordingly, microsomal cytochrome P-450 was reduced with 
NADPH in the presence of carbon monoxide which binds only the ferrous 
form of P-450, and the reduced hemoprotein was then allowed to react with 
known quantities of hydroperoxide under strict anaerobic conditions. The 
results (Table 24) show that after treatment with 0.16 mM cumene 
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TABLE 23 
STIMULATION OF MICROSOMAL NADPH-PEROXIDASE ACTIVITY BY 
PHENOBARBITAL TREATMENT a 
Activity 
NADPH-peroxidase 
(1) cumene hydroperoxide 
(2) progesterone 17a-
hydroperoxide 
NADPH-cytochrome c reductase 
Cytochrome P-450 
Cytochrome b 5 
Control 
4.8 
5.3 
57.0 
0.6 
0.40 
Phenobarbital-
induced 
36.0 
14.5 
131.0 
1.8 
0.51 
a Male Sprague-Dawley rats (250-300 g) were injected intraperitoneally 
with sodium phenobarbital (50 mg/kg) twice daily for 5 days. Control 
rats received an equivalent vol of 0.9% NaCl. Animals were sacrificed 
24 hr after the last injection, microsomes were prepared from perfused 
livers and enzyme activities determined on the pooled livers of 3 rats 
as described in Methods. NADPH-peroxidase activity is expressed as 
nmoles NADPH oxidized/min/mg protein, NADPH-cyt. c reductase as nmoles 
cyt. ~ reduced/min/mg protein, and cytochrome P-450 and b 5 contents as 
nmoles/mg protein. 
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TABLE 24 
OXIDATION OF THE NADPH-REDUCED CYTOCHROME P-450-CO COMPLEX 
BY CUMENE HYDROPEROXIDE a 
Addition 6A(450-490 nm) 
Microsomes + NADPH + CO 0.097 
Microsomes + NADPH +CO + 0.16 mM 
cumene hydroperoxide 0.057 
Microsomes + NADPH +CO + 0.16 mM 
cumene hydroperoxide + sodium dithionite 0.096 
Microsomes + NADPH + CO + 0.40 mM cumene 
a 
hydroperoxide 0.003 
To a reference cuvette and an anaerobic sample cuvette was added 3 ml 
of a mixture of liver microsomes (2 mg protein/ml) containing 0.1 M 
sodium phosphate buffer (pH 7.5) and 0.45 mM NADPH. Into the sidearm 
of the sample cuvette was placed a solution of cumene hydroperoxide. 
The sample cuvette was flushed with nitrogen (99.99% pure) for 20 min 
and then with CO that had been passed through a deoxygenating medium 
(83) for 5 min and the CO-difference spectrum was recorded using a 
Perkin-Elmer 356 dual wavelength spectrophotometer. The contents of the 
sample cuvette were then mixed with hydroperoxide (final cone. 0.16 mM 
and 0.40 mM, respectively) and the difference spectrum recorded. A few 
grains of sodium dithionite were added to the sample cuvette containing 
0.16 mM cumene hydroperoxide and the spectrum again measured. The 
reduction of cytochrome P-450 was determined at 450 nm relative to 
490 nm. 
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hydroperoxide, the reduced P-450-CO complex was decreased to 58% of 
the control value and after reaction with 0.4 mM cumene hydroperoxide, 
the hemoprotein-CO complex disappeared completely. That the disappear-
ance of the P-450-CO complex upon treatment with cumene hydroperoxide 
was not due to the destruction of the heme moiety of the hemoprotein 
was evidenced by the reappearance of a fully-developed P-450-CO complex 
upon reduction by sodium dithionite. The initial rate of oxidation of 
the · reduced P-450-CO complex at 450 nm could not be measured accurately 
since the reaction took place instantaneously even when low concentrat-
ions of hydroperoxide were employed. 
These results suggest that the ferrous form of cytochrome P-450 
can be oxidized very rapidly by cumene hydroperoxide. 
CHAPTER IV 
THE MICROSOMAL NADH-PEROXIDASE ELECTRON 
TRANSPORT SYSTEM 
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CHAPTER IV: THE MICROSOMAL NADH-PEROXIDASE ELECTRON TRANSPORT SYSTEM 
This chapter will examine the role of various electron 
transport components in the microsomal NADH-peroxidase enzyme system. 
MATERIALS AND METHODS 
Materials 
Trypsin, soybean trypsin inhibitor, nucleotides, and p-hydroxy-
mercuribenzoate were obtained from Sigma. Phenacetin was supplied by 
British Drug Houses, Toronto. All other reagents were of the highest 
grade commercially available. 
Assay of NADH-peroxidase activity 
Microsomal NADH-peroxidase activity was measured at 23° by 
following the rate of oxidation of NADH by hydroperoxides in the first 
min of reaction at 340 nm in the presence of microsomal fractions. The 
assay medium contained, unless otherwise stated, 0.067 M sodium phosphate 
buffer (pH 7.5), 0.27 M sucrose, 2 mg microsomal protein, 0.15 mM NADH, 
and 0.05 mM hydroperoxide in a final vol of 3 ml. Reaction rates were 
routinely corrected for NADH oxidation in the absence of hydroperoxide and 
-1 -1 
were calculated using an extinction coefficient for NADH of 6.22 em mM • 
Measurements were normally carried out with a Beckman DB-G double beam 
spectrophotometer. Turbidity in the sample solutions was balanced by 
using a reference cuvette containing 0.067 M sodium phosphate buffer 
(pH 7.5) and the same amount of microsomal protein as employed in the 
sample cuvette. Reactions which produced low velocities or those which 
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utilized large quantities of protein were measured with a Perkin-Elmer 
356 double beam spectrophotometer in the split beam mode. 
Determination of the Kro for NADH in the NADH-peroxidase reaction 
The K for NADH in the microsomal NADH-peroxidase reaction was 
m 
estimated by following the rate of oxidation of NADH at 340 nm on a 
Perkin-Elmer 356 recording spectrophotometer with a full-scale deflection 
of 0.1 absorbance units. The reaction medium consisted of 0.1 M sodium 
phosphate buffer (pH 7.5), 0.17 mg liver microsomal protein, varying 
amounts of NADH, and 0.8 mM cumene hydroperoxide in a final vol of 3 ml. 
Reaction rates were corrected for NADH oxidation in the absence of cumene 
hydroperoxide. 
Enzyme assays 
NADPH- or NADH-cytochrome £ reductase activity was measured at 
23° by following the rate of reduction of cytochrome £ (50 ~M) at 550 nm 
in a 3 ml solution containing 0.033 M sodium phosphate buffer (pH 7.5), 
0.15 mM NADPH or NADH, and a suitable amount of enzyme. NADH-cytochrome 
b 5 reductase activity was measured by following the rate of reduction of 
purified cytochrome b 5 (3.7 ~M) at 424 nm in a 3 ml solution containing 
0.033 M sodium phosphate buffer (pH 7.5), 0.15 mM NADH, and enzyme. 
NADH-ferricyanide reductase activity was determined at 420 nm in a 3 ml 
reaction vol containing 0.033 M sodium phosphate buffer (pH 7.5), 1 mM 
potassium ferricyanide, 0.15 mM NADH, and enzyme. The millimolar 
. . d. ff ( -l mM-1 ) b d d d . d. d 1 ext~nct~on ~ erences em etween re uce an ox1 ~ze e ectron 
acceptors used in calculating reaction rates were 21 at 550 nm for 
- 102 -
cytochrome~, 1.02 at 420 nm for potassium ferricyanide, and 100 at 424 
nm for cytochrome b 5 (98). 
Purification of microsomal components 
Cytochrome b 5 was prepared from liver microsomes by either 
trypsin digestion (98) or detergent solubilization (99). NADH-cytochrome 
b 5 reductase was prepared by either lysosomal digestion of liver microsomes 
according to Takesue and Omura (105, 106) or by detergent solubilization 
as described by Spatz and Strittmatter (107). Partially purified cyto-
chrome P-450 was prepared by chelate solubilization of liver microsomes 
according to Lu et al (23). Microsomal lipid was prepared by the method 
of Lu and coworkers (52). 
Preparation of lipid micelles 
Phosphatidy~holine, lysophosphatidylcholine, and phosphatidyl-
choline-lysophosphatidylcholine micelles were prepared by sonic oscillation 
in aqueous medium under nitrogen as described in Methods section in 
Chapter III. 
Preparation of antibodies 
Antibody to NADH-cytochrome b 5 reductase prepared by the method 
of Takesue and Omura (106) and antibody to cytochrome b 5 prepared according 
to Fukushima et al (97) was kindly supplied by Professor T. Omura, Kyushu 
University. Antiserum to NADPH-cytochrome ~reductase prepared by the 
method of Glazer et al (31) was kindly donated by Professor J.B. Schenkman , 
Yale University. 
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RESULTS 
The NADH-peroxidase assay 
NADH-peroxidase activity was followed by monitoring the rate 
of oxidation of NADH by hydroperoxides at 340 nm in the presence of 
microsomal fractions. Using cumene hydroperoxide as substrate and rat 
liver microsomes as the enzyme source, the reaction rate was found to be 
first-order with respect to microsomal protein concentration (Fig. 16). 
Using cumene hydroperoxide as substrate, an apparent K value of about 
m 
0.6 mM was obtained* (Fig. 17). Under these assay conditions, the rate 
of NADH oxidation was calculated to be approximately 37 nmoles/min/mg 
protein/~mole cumene hydroperoxide~ 
Measurement of the K for NADH in the microsomal NADH-peroxidase 
m 
reaction showed that an NADH concentration of 6 ~M gave an identical 
initial reaction rate (47 nmoles NADH oxidized/min/mg protein/~mole cumene 
hydroperoxide) to that obtained when higher concentrations of NADH were 
employed. It appears, therefore, that the K for NADH is smaller than 
m 
3 ~M. Strittmatter and Velick (40) reported a K for NADH of 2.7 ~M for 
m 
purified NADH-cytochrome b 5 reductase. 
Hydroperoxide specificity of microsomal NADH-peroxidase 
The hydroperoxide specificity of microsomal NADH-peroxidase is 
* A similar K value was obtained using a LineweaveP-BuPke plot. 
m 
** Under these assay conditions~ the reaction rate was f i rst-order with 
respect to microsomal protein concentration and first-order with respect 
to cumene hydroperoxide concentration. 
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Figure 16. Effect of increasing microsomal protein concentration on 
NADH-peroxidase activity. 
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The reaction was measured at 340 nm in a 3 ml system con-
- taining 0.067 M sodium phosphate buffer (pH 7.5), 0.15 mM 
NADH, specified concentrationsof liver microsomal protein, 
and 0.8 mM cumene hydroperoxide. 
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Figure 17. Effect of increasing cumene hydroperoxide concentration on 
microsomal NADH-peroxidase activity. 
The assay medium contained 0.067 M sodium phosphate buffer 
(pH 7.5), 0.15 mM NADH, 0.9 mg liver microsomal protein, and 
varying amounts of hydroperoxide in a final volume of 3 ml. 
Reaction rates were corrected for NADH oxidation in the 
absence of hydroperoxide. 
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presented in Table 25. The 17a-hydroperoxide derivatives of progesterone 
and pregnenolone were found to be effective substrates for the microsomal 
enzyme system of both liver and adrenal cortex. 
Tissue distribution of microsomal NADH-peroxidase activity 
In Table 26 is shown the tissue distribution of the microsomal 
NADH-peroxidase activity. It is observed that the microsomal fractions 
of tissues which contained high amounts of cytochrome P-450 per mg protein 
(e.g. liver, adrenal cortex) were the most active in catalyzing the NADH-
peroxidase reaction whereas microsomes from tissues that contained little 
or no cytochrome P-450 were either weakly active or completely inactive. 
However, the reaction rates were not strictly proportional to cytochrome 
P-450 content. 
The properties of the NADH-peroxidase enzyme system of rat liver 
microsomes were next examined in detail. 
Efficiency of NADH oxidation by hydroperoxides 
Examination of the stoichiometry of the NADH-peroxidase reaction 
revealed the oxidation of approximately 0.5 moles of NADH per mole of 
cumene hydroperoxide in the presence of liver microsomes under the normal 
assay conditions. This represents a 50% efficiency and indicates a com-
petition between NADH and certain microsomal constituents for the oxidizing 
equivalents of the hydroperoxide. Hydrogen donors other than NADH have 
been found to be oxidized by hydroperoxides at a similar efficiency in the 
presence of various heme catalysts (100-102). 
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TABLE 25 
HYDROPEROXIDE SPECIFICITY OF MICROSOMAL NADH-PEROXIDASEa 
Hydroperoxide 
Progesterone 17a-hydroperoxide 
Pregnenolone 17a-hydroperoxide 
Cumene hydroperoxide 
Cholesterol 7S-hydroperoxide 
Allopregnanolone 17a-hydroperoxide 
NADH-Peroxidase Activity 
liver 
microsomes 
6.8 
6.3 
5.8 
3.9 
2.9 
adrenocortical 
microsomes 
1.2 
0.8 
0.8 
a The oxidation of NADH by hydroperoxides in the presence of microsomal 
fractions was measured at 340 nm as described in Methods. Reaction 
rates are expressed as nmoles NADH oxidized/min/mg protein. 
A hydroperoxide cone. of 0.05 mM was employed. 
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TABLE 26 
TISSUE DISTRIBUTION OF MICROSOMAL NADH-PEROXIDASE ACTIVITY a 
NADH-Peroxidase 
Source of Microsomes P-450 Content Activity 
Liver 0.70 80.8 
Adrenal cortex b 0.60 4.8 
Kidney 0.25 3.4 
Lung 0.05 2.9 
Testis 0.02 0 
Small Intestine 0.02 0 
Brain 0 0 
Heart 0 0 
Skeletal muscle c 0 0 
a Microsomes from various tissues of the rat were prepared and the P-450 
b 
c 
content (nmoles/mg protein) determined. NADH-peroxidase activity was 
measured at 340 nm in a 3 ml solution containing 0.067 M sodium phos-
phate buffer (pH 7.5), 0.15 mM NADH, 1 mg microsomal protein,and 0.8 mM 
cumene hydroperoxide. Reaction rates were corrected for NADH oxidation 
in the absence of hydroperoxide and are expressed as nmoles NADH 
oxidized/min/mg protein. 
Adrenal cortex microsomes were obtained from bovine adrenals. 
The hind legs of the rat were used for the source of skeletal muscle. 
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Effect of pH and ionic strength on NADH-peroxidase activity 
The pH dependence of the microsomal NADH-peroxidase activity 
is illustrated in Fig. 18. A maximal reaction rate in 0.1 M sodium 
phosphate buffer was obtained between pH 7.7 and 7.8. 
In Fig. 19 is shown the effect of ionic strength on the micro-
somal NADH-peroxidase reaction. It is seen that the activity was stim-
sulated by increasing concentrations of sodium phosphate buffer. KCl 
exhibited a similar stimulatory effect when tested at the same ionic 
strengths as phosphate. 
Inhibition of NADH-peroxidase activity by various reagents 
The effect of various inhibitors on the microsomal oxidation of 
NADH by cumene hydroperoxide was next examined. It was found that the 
enzyme system was heat labile, being totally inactivated by preincubation 
of liver microsomes at 80° for 5 min (Table 27). Measurement of the activ-
ity under a nitrogen or a carbon monoxide atmosphere produced no appreciable 
inhibition. NAD+ and 2-phenyl-2-propanol did not affect the reaction rate. 
Acetone and tert. amyl alcohol, reagents that are known to convert cytochrome 
P-450 to its inactive P-420 form (103), were potent inhibitors of the reaction. 
Evidence for the involvement of NADH-cytochrome b 5 reductase in NADH-
peroxidase activity 
The activity of microsomal NADH-cytochrome b 5 reductase is markedly 
inhibited by low concentrations of sulfhydryl reagents such as £-mercuri-
benzoate (108, 109). Preincubation of the flavoenzyme with NADH prior to 
treatment with p- mercuribenzoate partially protects the flavoprotein 
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Figure 18. The pH dependence of the microsomal NADH-peroxidase reaction. 
20 
16 
12 
8 
4 
6 
The assay medium consisted of 0.1 M sodium phosphate buffer 
of varying pH, 1 mg liver microsomal protein, 0.15 mM NADH, 
and 0.4 mM cumene hydroperoxide in a final volume of .3 ml. The 
pH was ·routinely checked at the end of the reaction. 
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Figure 19. Effect of ionic strength on NADH-peroxidase activity. 
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The reaction medium contained 0 . 067 M sodium phosphate 
buffer (pH 7.5), 0.15 mM NADH, 1 mg liver microsomal 
protein, and 0.4 mM cumene hydroperoxide to which increas-
ing amounts of KCl or additional phosphate was added to 
obta~n desired ionic strengths. Final ionic strength was 
calculated from the concentrations of phosphate and added 
KCl. 
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TABLE 27 
EFFECT OF VARIOUS INHIBITORS ON NADH-PEROXIDASE ACTIVITY a 
Inhibitor % Inhibition 
Heat (80° for 5 min) 100 
N. b ltrogen 8 
Carbon monoxide c 7 
NAD+ (0.45 mM) 8 
2-Phenyl-2-propanol (0.4 mM) 8 
tert. Amyl alcohol (7%) 98 
Acetone (5%) 73 
a 
b 
c 
The assay medium contained 0.067 M sodium phosphate buffer (pH 7.5), 
0.15 mM NADH, 1 mg liver microsomal protein, specified amounts of 
inhibitor, and 0.4 mM cumene hydroperoxide in a final vol of 3 ml. The 
specific activity of the NADH-peroxidase system in the absence of in-
hibitor, in terms of nmoles NADH oxidized/min/mg protein, was 42. 
The contents of an anaerobic cuvette were gassed with nitrogen (99.99% 
pure) for 10 min prior to addition of cumene hydroperoxide. 
The contents of an anaerobic cuvette were gassed with nitrogen for 
10 min and CO that had been passed through a deoxygenation medium (83) 
for 5 min prior to addition of cumene hydroperoxide. 
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from inactivation. The results (Table 28) show that microsomal NADH-
peroxidase activity was markedly inhibited by 0.05 mM p-hydroxymercuri-
benzoate and preincubation of microsomes with NADH prior to addition of 
sulfhydryl inhibitor partially protected the enzyme system from inactiv-
ation. 
Antibody prepared to NADH-cytochrome b 5 reductase was next used 
to evaluate further the role of the flavoprotein reductase in the micro-
somal NADH-peroxidase reaction. The results (Table 28) indicate a 30% 
inhibition of the reaction rate by 20 mg antibody per mg microsomal pro-
tein. NADH-ferricyanide reductase activity, a function associated with 
the enzyme NADH-cytochrome b 5 reductase (106), was inhibited 50% at the 
same antibody: protein ratio. On the other hand, NADPH-cytochrome £ 
reductase was not affected by the antibody. Unfortunately, the limited 
supply of antibody precluded an extensive analysis of the inhibitory effect. 
Although not conclusive, these results suggest the involvement of 
NADH-cytochrome b 5 reductase as one of the electron carriers in the micro-
somal NADH-peroxidase enzyme system. 
Inhibition of NADH-peroxidase activity by modifiers of cytochrome P-450 
It is well established that type I, type II, and modified type II 
substrates interact with microsomal cytochrome P-450 to produce character-
istic spectral changes (34, 35). The NADH-peroxidase enzyme system was 
found to be sensitive to inhibition by these substances (Table 29). Steroids 
forming type I spectra with microsomal P-450 were effective inhibitors as 
were the type II and modified type II compounds. Other steroid substrates 
TABLE 28 
INHIBITION OF NADH-PEROXIDASE ACTIVITY BY INHIBITORS OF 
NADH-CYTOCHROME b5 REDUCTASE a 
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Inhibitor % Inhibition 
£-Hydroxymercuribenzoate (0.05 mM) 81 
b £-Hydroxymercuribenzoate after NADH 55 
c Antibody to NADH-cyt. E5 reductase 30 
a 
b 
c 
(20 mg/mg microsomal protein) 
NADH-peroxidase activity was measured in the presence of specified 
amounts of inhibitor as described in Table 27. ~-Hydroxymercuribenzoate 
(0.05 mM) was incubated with 1 mg liver microsomal protein in 0.067 M 
sodium phosphate buffer (pH 7.5) for 2 min directly in the assay cuvette. 
After incubation, NADH (0.15 mM) and cumene hydroperoxide (0.4 mM, final 
cone.) were added and activity determined in a final vol of 3 ml. 
Liver microsomes were incubated with NADH for 1 min prior to addition of 
£-hydroxymercuribenzoate and hydroperoxide. 
Microsomes were incubated with indicated amount of antibody at 23° for 
5 min directly in the assay cuvette in a 1 ml solution containing 0.1 M 
sodium phosphate buffer (pH 7.5). After incubation the rest of the assay 
components were added to make up a total vol of 3 ml. The cumene hydro-
peroxide cone. used was 0.8 mM. 
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TABLE 29 
INHIBITION OF NADH-PEROXIDASE ACTIVITY BY P-450 MODIFIERSa 
Type I Compound % Inhibition 
Androstenedione (0.1 roM) 70 
Testosterone (0.1 roM) 49 
17S-Estradiol (0.1 roM) 40 
Aminopyrine (5 mM) 25 
Type II Ligand 
Imidazole (2 roM) 81 
n-Octylamine (0.5 roM) 73 
Pyridine (5 roM) 58 
Aniline (5 roM) 62 
Modified Type II Compound 
Potassium Cyanide (1 rnM) 58 
Phenacetin (1 roM) 57 
Corticosterone (0.1 roM) 45 
Steroid Inhibitor 
Progesterone (0.1 roM) 55 
Deoxycorticosterone (0.1 roM) 49 
17a-Hydroxyprogesterone (0.1 mM) 40 
a NADH-peroxidase activity was measured in the presence of specified 
amounts of various inhibitors as described in Table 27. 
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such as progesterone, 17a-hydroxyprogesterone, and deoxycorticosterone 
were also found to act as efficient inhibiting agents. 
The effect of various reagents that convert cytochrome P-450 
to P-420 on microsomal NADH-peroxidase activity is shown in Table 30. It is 
observed that reagents which effected the conversion of cytochrome P-450 to 
P-420 (e.g. detergents, alcohols, protein denaturants) produced a parallel 
inhibition of NADH-peroxidase activity. These P-450 modifiers did not 
inhibit the activity of the flavoenzyme NADH-cytochrome b 5 reductase to 
any significant extent, indicating that the diminution in NADH-peroxidase 
activity occurred as a consequence of the conversion of P-450 to P-420 
rather than as a result of an inactivation of the flavoprotein reductase. 
The inhibition of NADH-peroxidase activity by various P-450 
modifiers suggests the participation of cytochrome P-450 in the microsomal 
NADH-peroxidase system. 
Inhibition of NADH-peroxidase activity by cyanide 
Gaylor and associates (57) examined the binding offue modified 
type II ligand, cyanide, to the oxidized forms of cytochrome P-450 in liver 
microsomes. Two binding constants for cyanide of 0.5 mM and 2.5 mM were 
obtained suggesting the presence inliver microsomes of two different species 
of cytochrome P-450. The species of P-450 that exhibited the higher affinity 
for cyanide was postulated to be involved in the NADH-dependent sterol 
demethylation activity, a reaction that is inhibited 50% by 0.5 mM cyanide 
(57-59). Cyanide was found to be an effective inhibitor of the NADH-peroxi-
dase reaction (Fig. 20), a 50% inhibition occurring at a cyanide 
TABLE 30 
INHIBITION OF NADH-PEROXIDASE ACTIVITY BY REAGENTS THAT CONVERT 
CYTOCHROME P-450 TO P-420 a 
P-450 Modifier % Inhibition % p...;..420 Formed 
None 0 0 
Sodium dodecyl sulfate (0.1 %) 95 98 
Sodium deoxycholate (0.5%) 86 90 
Sodium cholate (1%) 71 50 
Lubrol WX (1%) 75 40 
Urea (4 M) 62 55 
n-Propanol (15%) 98 100 
T . b rypsln 45 43 
a Liver microsomes (5 mg protein/ml) were incubated at 23° for 20 min 
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with specified amounts of P-450 modifier in 0.1 M sodium phosphate 
buffer (pH 7.4) containing 0.4 mM EDTA and 0.05 M sucrose in a final 
vol of 3 ml. NADH-peroxidase and NADH-cyt. E5 reductase activities 
and the extent of conversion of P-450 to P-420 were determined. 
b Liver microsomes at a protein cone. of 10 mg/ml were incubated at 
15° for 15 hr with trypsin (25 ~g/mg protein) in 0.05 M sodium 
phosphate buffer (pH 7.4) containing 0.3 M sucrose and 2 mM EDTA. 
NADH-peroxidase activity and the extent of conversion of P-450 to 
P-420 were determined. 
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Figure 20. Cyanide inhibition curve for microsomal NADH-peroxidase 
activity. 
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The reaction medium consisted of 0.067 M sodium phosphate 
buffer (pH 7.5), 0.15 mM NADH, 1 mg liver microsomal protein, 
varying concentrations of potassium cyanide, and 0.4 mM cumene 
hydroperoxide. 
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[KCN], mM 
concentration of about 0.45 mM. These results are suggestive of an 
involvement in the NADH-peroxidase reaction of the P-450 species that 
exhibits the higher affinity for cyanide. 
Stimulation of NADH-peroxidase activity by phenobarbital treatment 
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The effect of phenobarbital pretreatment of rats on microsomal 
NADH-peroxidase activity and other components of liver microsomes is illu-
strated in Table 31. The specific activity of the NADH-peroxidase enzyme 
system was enhanced 10-fold when cumene hydroperoxide was employed as 
substrate and 2.7-fold when progesterone 17a-hydroperoxide was used as sub-
strate. Cytochrome P-450 showed a 3-fold increase in specific content 
whereas the cytochrome b 5 level was only slightly elevated. On the other 
hand, NADH-cytochrome ~reductase activity, a cytochrome ~-dependent 
function, was diminished 1.7-fold by the phenobarbital treatment. 
Cytochrome b 5 and microsomal NADH-peroxidase activity 
Since cytochrome b 5 is one of the electron carriers that can accept 
reducing equivalents from NADH via NADH-cytochrome b 5 reductase, it was of 
considerable interest to determine whether the hemoprotein plays a role in the 
microsomal NADH-peroxidase enzyme system. When purified cytochrome b 5 (0.4 ~M 
final cone.) prepared by either trypsin solubilization (98) or detergent 
solubilization (99) was added to the NADH-peroxidase assay medium and the 
microsomal activity measured, no change in the reaction rate was observed. 
Antibody prepared against cytochrome b 5 was next used to evaluate 
further the role of the hemoprotein in the reaction. Preincubation of liver 
microsomes with 6 mg antibody per mg protein for 5 min and subsequent 
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TABLE 31 
STIMULATION OF MICROSOMAL NADH-PEROXIDASE ACTIVITY 
BY PHENOBARBITAL TREATMENT a 
Activity 
NADH-peroxidase 
1) cumene hydroperoxide 
2) progesterone 17a-hydroperoxide 
NADH-cytochrome £ reductase 
Cytochrome P-450 
Cytochrome b 5 
Control 
4.8 
5.3 
449.0 
0.6 
0.4 
Phenobarbital-
Induced 
48.0 
14.5 
268.0 
1.8 
0.51 
a Male Sprague-Dawley rats (250-300 g) were injected intraperitoneally 
with sodium phenobarbital (50 mg/kg) twice daily for 5 days. Control 
rats received an equivalent vol of 0.9% NaCl. Animals were sacrificed 
24 hr after the last injection, microsomes were prepared from perfused 
livers and enzyme activities determined on the pooled livers of 3 rats 
as described in Methods. NADH-peroxidase and NADH-cyt. c reductase 
activities are expressed as nmoles NADH oxidized/min/mg protein and 
nmoles cyt. £ reduced/min/mg protein, respectively, whereas cyt. b 5 
and P-450 contents are given as nmoles/mg protein. 
- 121-
measurement of NADH-peroxidase activity by the normal procedure produced 
no inhibition of the reaction rate. On the other hand, this same antibody: 
protein ratio inhibited NADH-cytochrome c reductase activity, a cytochrome 
b 5 -dependent function, by 45%. 
These results argue against the participation of cytochrome b 5 
in the NADH-peroxidase reaction. 
NADPH-cytochrome c reductase and NADH-peroxidase activity 
The activity of NADPH-cytochrome £ reductase is markedly inhibited 
by NADP+ and by antibody prepared against the flavoenzyme. These modifiers 
were previously found to be potent inhibitors of the NADPH-dependent 
peroxidase activity (see Chapter III). When tested in their ability to 
inhibit the NADH-dependent peroxidase activity, NADP+ (0.6ITM) and anti-
body to the flavoprotein (8 mg/mg microsomal protein) were found to be 
completely ineffective in inhibiting the reaction rate. These results 
indicate that the flavoenzyme does not participate in the NADH-dependent 
peroxidase reaction. 
Effect of trypsin on microsomal NADH-peroxidase activity 
Previous investigators (38) have demonstrated that treatment of 
liver microsomes with trypsin completely solubilizes NADPH-cytochrome £ 
reductase and cytochrome b 5 from the microsomal membrane but leaves the 
major portion of NADH-cytochrome b 5 reductase and hemoprotein P-450 still 
intact. Accompanying the solubilization of cytochrome b 5 is a drastic 
reduction in NADH-cytochrome £reductase activity. 
The present study has utilized proteolytic digestion as a means 
of further identifying the microsomal components involved in the NADH-
peroxidase enzyme system. The results (Table 32) show that incubation 
of microsomal fraction at 10° with 25 ~g trypsin/mg protein for 15 hr 
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resulted in a 48% inhibition of NADH-peroxidase activity. This inactiv-
ation was probably due to the conversion of cytochrome P-450 to P-420 since 
the trypsin treatment converted 38% of the hemoprotein into the inactive 
form. NADH-cytochrome ~ reductase activity was inhibited 96% by the trypsin 
digestion presumably as a result of the solubilization of cytochrome b 5 . On 
the other hand, NADH-ferricyanide reductase activity, a function which is 
associated with the enzyme NADH-cytochrome ~ reductase, was only slightly 
diminished. 
The residual NADH-peroxidase activity was recovered mainly in the 
pellet fraction (70%) after centrifugation of the tryptic digest. NADH-
ferricyanide reductase activity and cytochrome P-450 showed a similar 
pattern of distribution whereas cytochrome b 5 was recovered exclusively in 
the supernatant fraction. The treatment solubilized over 95% of the NADPH-
cytochrome ~ reductase activity and about 50% of the total microsomal pro-
tein. Addition to the pellet fraction of an excess of either purified 
NADPH-cytochrome £reductase or cytochrome b 5 , prepared by trypsin digestion 
of liver microsomes (98), did not increase the NADH-peroxidase activity. 
Reconstitution of the microsomal NADH-peroxidase activity 
Since our results have implicated NADH-cytochrome b 5 reductase 
and cytochrome P-450 as electron carriers in the microsomal NADH-peroxidase 
enzyme system, an attempt was made to solubilize and resolve the enzyme 
system into its component parts and to reconstitute the activity. Purified 
TABLE 32 
EFFECT OF TRYPSIN DIGESTION OF LIVER MICROSOMES ON NADH-PEROXIDASE ACTIVITY AND OTHER MICROSOMAL CONSTITUENTS a 
Microsomal NADH-Cyt. c 
-
NADH-Ferricyanide 
Preparation NADH-Peroxidase Reductase Reductase Cyt. P-450 Cyt. P-420 Cyt. bs 
Specific Percent Specific Specific Percent Specific Percent Specific Specific Percent 
Activity Recovery Activity Activity Recovery Activity Recovery Activity Activity Recovery 
Liver microsomes 44 985 4.2 0.79 0.03 0.57 
Trypsin-treatedb 
microsomes 23 31 3.8 0.45 0.28 0.50 
Supernatant 13 30 17 1.3 27 0.15 18 0.29 0.73 95 
Pellet 24 70 43 3.7 73 0.68 82 0.19 0.04 5 
a Liver microsomes (10 mg protein/ml) were incubated at 10° with 25 ~g trypsin/mg protein for 15 hr in 0.05 M sodium 
phosphate buffer (pH 7.4) containing 0.3 M sucrose and 2 rnM EDTA. Reaction was stopped by addition of trypsin inhibitor 
(1 mg/mg trypsin). The digest was spun at 105,000 a for 2 hr, pellet was suspended in 0.3 M sucrose-2 rnM EDTA (pH 7.4) 
and enzymes of various fractions assayed. NADH-peroxidase activity was measured using 0.4 mM cumene hydroperoxide. NADH-
peroxidase, NADH-cyt. c reductase, and NADH-ferricyanide reductase activities are expressed as nmoles NADH oxidized/min/ 
mg protein, nmoles cyt~ c reduced/min/mg protein, and ~moles ferricyanide reduced/min/mg protein, respectively, and 
cytochrome contents are given as nmoles/mg protein. % recoveries in the supernatant and pellet fractions were calculated 
by taking the activities in the trypsin digest as 100%. Values are expressed as % of residual activity recoverable. 
Actual total recoveries were greater than 90%. 
b 
Trypsin-treated microsomes refers to a mixture of soluble and particulate materials obtained after treatment of liver 
microsomes with trypsin as described above. 
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NADH-cytochrome b 5 reductase was prepared by lysosomal digestion of liver 
microsomes according to Takesue and Omura (105, 106). The purified pre-
paration catalyzed the reduction of 100 nmoles cytochrome b 5 /min/mg 
protein when 3.7 ~M purified cytochrome b 5 was employed in the assay 
medium. Partially purified cytochrome P-450 was prepared by chelate solu-
bilization of liver microsomes following the method of Lu et al (23). 
The final preparation contained 0.56 nmoles P-450 per mg protein. 
The effect of varying the concentration of purified NADH-cyto-
chrome b 5 reductase and cytochrome P-450 on NADH-peroxidase activity is 
shown in Fig. 21. The reaction rate was found to be proportional to the 
concentration of the reductase and of cytochrome P-450. Similar kinetics 
were obtained when detergent-solubilized NADH-cytochrome ~ reductase was 
substituted for lysosomal-solubilized enzyme. However, the cytochrome P-450 
preparation was notpure and contained a significant amount of NADH-cytochrome 
b 5 reductase activity (15 nmoles cytochrome b 5 reduced/min/mg protein). The 
presence of this enzyme in the P-450 preparation may accountfor the low 
stimulation of NADH-peroxidase activity upon addition of increasing amounts 
of purified flavoenzyme (Fig. 21). It is, therefore, apparent that more 
efficient reconstitution of the NADH-peroxidase activity must await further 
purification of cytochrome P-450. 
A comparison of the effectiveness of liver microsomes and the 
reconstituted enzyme system in catalyzing the NADH-peroxidase reaction is 
shown in Table 33. The specific activity of the reconstituted system using 
either detergent-solubilized or lysosomal-solubilized reductase was about 
25% of that originally present in liver microsomes. Addition to the recon-
stituted system of either trypsin-solubilized or detergent-solubilized 
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Figure 21. Effect of increasing concentrations of purified NADH-
cytochrome b 5 reductase and cytochrome P-450 on NADH-peroxidase activity. 
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The assay medium contained 0.067 M sodium phosphate buffer 
(pH 7.5), 0.15 mM NADH, varying concentrations of purified 
NADH-cytochrome b 5 reductase or cytochrome P-450, and 0.8 mM cumene hydroperoxide in a final volume of 3 ml. When 
the concentration of reductase was varied, 0.2 ~M P-450 was 
used and when the P-450 concentration was varied, 130 ~g 
reductase (specific activity, 100 nmoles cytochrome b 5 
reduced/min/mg protein) was employed. Reaction rat~s were 
corrected for NADH oxidation in the absence of reductase or 
P-450, respectively. 
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TABLE 33 
A COMPARISON OF NADH-PEROXIDASE ACTIVITY IN LIVER MICROSOMES 
AND THE RECONSTITUTED ENZYME SYSTEM a 
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Addition 
NADH-Peroxidase 
Activity 
Liver microsomes 87 
Detergent-solubilized NADH-cyt. b 5 reductase 
+ P-450 20 
Detergent-solubilized NADH-cyt. ~ reductase 
+ P-450 + 1.0 mg phosphatidylcholine-
lysophosphatidylcholine micelles b 23 
Lysosomal-solubilized NADH-cyt. b 5 reductase 
a 
b 
+ P-450 15 
NADH-peroxidase activity in liver microsomes was measured at 340 nm in 
a 3 ml system containing 0.067 M sodium phosphate buffer (pH 7.5), 
0.15 mM NADH, 1 mg microsomal protein, and 0.8 mM cumene hydroperoxide. 
In the reconstituted system, 0.5 ~M purified P-450 plus an excess of 
either detergent-solubilized or lysosomal-solubilized NADH-cyt. b 5 
reductase were substituted for liver microsomes. Reaction rates are 
expressed as nmoles NADH oxidized/min/nmole P-450. 
Phosphatidylcholine-lysophosphatidylcholine micelles containing an equal 
amount of each component were prepared in aqueous medium by sonication 
as described in Methods. The micelles were preincubated with the reduct-
ase and P-450 for 5 min prior to addition of NADH and hydroperoxide. 
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cytochrome b 5 (0.4 ~M) did not enhance the reaction rate. 
Jones and Wakil (110) have demonstrated a requirement for phos-
phatidylcholine-lysophosphatidylcholine lipid by microsomal NADH-cytochrome 
c reductase. The effect· of phosphatidylcholine-lysophosphatidylcholine 
micelles on the NADH-peroxidase activity of the reconstituted system is 
presented in Table 33. The reaction rate was slightly enhanced by the 
addition of these lipid micelles. Microsomal lipid (0.2 mg) prepared by 
the method of Lu et al (52) had no stimulatory effect. 
Oxidation of NADH-reduced cytochrome P-450 by hydroperoxides 
Our results have implicated cytochrome P-450 as an electron 
carrier in the microsomal NADH-peroxidase reaction and it was therefore 
necessary to determine whether the reduced form of the hemoprotein could 
be oxidized by hydroperoxides. Accordingly, microsomal cytochrome P-450 
was reduced with NADH in the presence of carbon monoxide which binds only the 
ferrous form of P-450 and the reduced hemoprotein was allowed to react 
with known quantities of hydroperoxide under strict anaerobic conditions. 
The results (Table 34) indicate that after treatment with 0.16 mM cumene 
hydroperoxide, the reduced P-450-CO complex was decreased to 38% of the 
control value and after reaction with 0.4 mM cumene hydroperoxide, the 
hemoprotein-CO complex was oxidized completely. The disappearance of 
the P-450-CO complex upon treatment with cumene hydroperoxide was not due 
to the destruction of the hemoprotein since a fully developed P-450-CO 
complex reappeared upon reduction by sodium dithionite. The initial rate 
of oxidation of the complex at 450 nm was too rapid to be measured by 
conventional methods even when low concentrations of hydroperoxide were 
employed. 
TABLE 34 
OXIDATION OF THE NADH-REDUCED CYTOCHROME P-450-CO COMPLEX 
a BY CUMENE HYDROPEROXIDE 
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Addition ~A (450-490 nm) 
Micro somes + NADH + co 0.075 
Microsomes + N~H + co + 0.16 mM cumene 
hydroperoxide 0.028 
Microsomes + NADH + co + 0.16 mM cumene 
hydroperoxide + sodium dithionite 0.073 
Microsomes + NADH + CO+ 0.4 mM cumene 
a 
hydroperoxide 0 
To a reference cuvette and an anaerobic sample cuvette was added 3 ml 
of a mixture of liver microsomes (2 mg protein/ml) containing 0.1 M 
sodium phosphate buffer (pH 7.5) and 0.45 mM NADH. Into the sidearm of 
the sample cuvette was placed a solution of cumene hydroperoxide. The 
sample cuvette was flushed with nitrogen for 20 min and with CO that had 
been passed through a deoxygenating medium (83) for 5 min and the co-
difference spectrum was recorded. The contents of the sample cuvette 
were then mixed with hydroperoxide (final cone. 0.16 mM and 0.40 mM, 
respectively) and the difference spectrum recorded. A few grains of 
sodium dithionite were added to the sample cuvette containing 0.16 mM 
cumene hydroperoxide and the spectrum again was measured. The reduct-
ion of cytochrome P-450 was determined at 450 nm relative to 490 nm. 
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These results indicate that the NADH-reduced form of cytochrome 
P-450 can be oxidized very rapidly by cumene hydroperoxide. 
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DISCUSSION 
Cytochrome P-450 as a microsomal peroxidase in steroid hydroperoxide 
decomposition 
In an effort to determine the mechanism by which various hydro-
peroxides are decomposed within the cell and in seeking to establish the 
possible role of organic hydroperoxides as transient species in biological 
hydroxylation reactions, the decomposition of steroid and other organic 
hydroperoxides by hepatic and adrenocortical microsomes using TMPD as an 
electron donor has been examined. Strong evidence has been presented that 
cytochrome P-450 is the microsomal peroxidase responsible for the decom-
position of these hydroperoxides. 
Cytochrome P-450 is the oxygen-activating pigment involved in 
many hydroxylation and demethylation reactions. A prerequisite for enzymic 
hydroxylation is that the substrate be bound to the hemoprotein catalyst 
during the course of the hydroxylation reaction. The reactive area of cyto-
chrome P-450, i.e., the vicinity of the heme, appears to be buried in a highly 
hydrophobic portion of P-450 protein or phospholipid of the microsomal 
membrane and this hydrophobic environment seems to be essential for sub-
strate hydroxylation (37). Reagents such as proteases, certain detergents, 
acid or base, phospholipases, alcohols, sulfhydryl reagents can alter the 
hydrophobic environment of the heme or the conformation of cytochrome P-450 
and convert the hemoprotein into its inactive P-420 form. This modification 
is usually* accompanied by an inactivation of hydroxylating activity (11, 42). 
In this study the peroxidase activity of microsomal fractions was inhibited 
* An enzyme system from Pseudomonas aminovorans contains an enzymically 
active cytochrome P-420-type hemoprotein which catalyzes the NAD(P)H-
dependent oxidation of amines in the presence of oxygen (l24). 
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by reagents that convert cytochrome P-450 to cytochrome P-420. Since 
cytochrome P-420 does not exhibit substrate binding (45, 85), this could 
explain its ineffectiveness in catalyzing the peroxidase reaction with 
cumene hydroperoxide and steroid hydroperoxides as substrates. 
In contrast, cytochrome P-420 was a very active peroxidase 
towards linoleic acid hydroperoxide (89). Since fatty acids such as lino-
leic acid have a strong binding affinity for cytochrome P-450 as well as 
other proteins in general (111), the effectiveness of cytochrome P-420 in 
acting as a peroxidase for linoleic acid hydroperoxide may be due to the 
avid binding of the hydroperoxide to the hemoprotein catalyst which could 
then result in effective peroxidase action. Furthermore, fatty acid 
hydroperoxides are unique among the hydroperoxides in that they can act as 
effective substrates for a wide variety of heme compounds (e.g. cytochrome 
P-450, cytochrome P-420, hematin, methemoglobin, cytochrome c) whereas 
most steroid hydroperoxides and cumene hydroperoxide seem to be effective 
only with hemoprotein P-450, with the exception of progesterone 17a-hydro-
peroxide which is also a very good substrate for hematin. 
The peroxidase activity of microsomal fractions was inhibited by 
compounds that form type I, type II,and modified type II difference spectra 
with cytochrome P-450. The type II ligands were generally more inhibitory 
than the type I and modified type II compounds. A possible explanation for 
this result lies in the different binding sites for type I , type II and 
modified type II compounds on the P-450 molecule. It is generally recognized 
that the heme iron is the active site which is responsible for the peroxidase 
activity of hemoproteins. Therefore, type II ligands which bind directly to 
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the heme iron of P-450 to form a hemichrome (35) would be expected to 
exert a more pronounced inhibition than type I or modified type II com-
pounds which interact with some other portion of the P-450 molecule (35). 
Cytochrome P-450 in microsomes exists both in a free state and 
in a form bound to endogenous substrate (i.e. steroids). A prerequisite 
for peroxidase activity is that the hydroperoxide be bound to the hemo-
protein peroxidase at some stage of catalysis. Accordingly, the ease with 
which hydroperoxide can bind to a particular form of P-450 should deter-
mine the effectiveness of that form in catalyzing the peroxidase reaction. 
To what extent the substrate-bound form of P-450 is active in catalyzing 
hydroperoxide decomposition will most likely depend on the precise site 
on the P-450 molecule at which the substrate is attached. For example, 
if the substrate is bound directly to the heme iron of P-450 as are type 
II ligands, then it may seriously interfere with the interaction of the 
hydroperoxide and the hemoprotein and may thereby inhibit catalysis of the 
peroxidase reaction, unless the hydroperoxide can displace the substrate 
from its binding site. If the substrate is bound at a site other than the 
heme iron residue, such as the type I or the modified type II binding site, 
inhibition of peroxidase activity will occur only when the substrate inter-
feres with the binding of the hydroperoxide to the "active center" of P-450. 
Cytochrome P-450 has been isolated from hepatic microsomes and 
from adrenocortical mitochondria and microsomes as a mixture of two 
forms: high spin P-450 in which the Fe 3+ heme is detectable in a high 
spin state and low spin P-450 in which the heme iron is in a low spin 
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state (16, 85, 86). Interaction of cytochrome P-450 with various steroid 
or drug substrates appears to cause a shift in the proportion of one spin 
state to the other, leading to the characteristic induced type I (high spin) 
or type II (low spin) difference spectra. The two forms of P-450 in adreno-
cortical mitochondria are in fact able to catalyze completely separate 
enzymic reactions, the low spin form functioning in liS-hydroxylation and 
the high spin form being responsible for side chain cleavage activity (11). 
Low spin cytochrome P-450 appears to be responsible for the peroxidase 
activity of liver and adrenocortical microsomes since both of these fractions 
contain the predominantly low spin form of the cytochrome (45, 85). Inhibitor 
studies with n-octylamine reported in this study further strengthen this con-
clusion. 
The level of cytochrome P-450 in liver microsomes is markedly in-
creased by treatment of animals with various drugs such as phenobarbital or 
with polycyclic carcinogens such as 3-methylcholanthrene (41). In this 
study the peroxidase activity inliver microsomes of phenobarbital-induced 
rats showed a similar increase to the rise in P-450 content when progesterone 
17a-hydroperoxide was used as substrate. In contrast, the specific activity 
of microsomal peroxidase with cumene hydroperoxide as substrate was 
enhanced markedly by phenobarbital treatment, an increase which was several 
times more than could be accounted for by the rise in P-450 content. 
Several possible explanations could account for the difference in the rates 
of decomposition of the two hydroperoxides by microsomes from phenobarbital-
treated rats: 1) the hydroperoxides bind at a different catalytic site on 
the P-450 molecule; 2) phenobarbital treatment changes the hydrophobic 
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environment of the P-450 heme (46) or/and the conformation of cytochrome 
P-450 and modifies the hydroperoxide-binding site in such a manner as to 
make the hemoprotein selectively more active as a peroxidase towards 
cumene hydroperoxide. After 3-methylcholanthrene treatment, the specific 
activity of microsomal peroxidase using progesterone 17a-hydroperoxide as 
substrate increased proportionally to P-450 content whereas with cumene 
hydroperoxide as substrate, the peroxidase activity showed a substantial 
decrease. Therefore, it appears that 3-methylcholanthrene-induced P-450 is 
just as effective a peroxidase for progesterone 17a-hydroperoxide, but is a 
less effective peroxidase for cumene hydroperoxide, than is normal P-450. 
This induction study indicates that differences exist in the 
selectivity and rates of metabolism of various hydroperoxides by the 
different forms of P-450 in liver microsomes from induced animals. Differ-
ences in the rates of hydroxylation of various drugs and steroids by 
induced forms of liver microsomal P-450 have been reported (7, 45, 104). 
Environmentally-induced changes in drug metabolism (e.g. changes in nutrit-
ional or hormonal status, stress, alteration of atmospheric pressure, 
fasting, administration of various drugs and carcinogens) have been assoc-
iated with changes in hepatic microsomal P-450 content (45) and what effect 
these environmental factors will have on microsomal TMPD-peroxidase activity 
remains to be determined. 
Mitton et al (112) found that cholesterol Sa- and 7a-hydroper-
oxides*were converted in significant yield to the corresponding hydroxy 
derivatives by an aqueous liver extract. Incubation of cumene hydroper-
oxide and the 17a-hydroperoxides of progesterone and pregnenolone with 
* cholesterol 5a-hydroperoxide = cholest-6-en-3B-ol 5a-hydroperoxide 
cholesterol ?a-hydroperoxide = cholest-5-en-3B-ol ?a-hydroperoxide 
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hepatic or adrenocortical microsomes also gives rise to the corresponding 
hydroxy derivatives as the major products. Thus, a general mechanism for 
microsomal TMPD-peroxidase activity is proposed in scheme 2. It is 
suggested that ferric hemoprotein P-450 initially reduces hydroperoxide 
(ROOH) to a hydroxy derivative (ROH) and in the process the hemoprotein 
5+ is converted to a higher oxidation state, the perferryl (Fe ) form, which 
is responsible for the oxidation of TMPD to Wurster's blue. Cyanide 
complexes with the ferric form of P-450 and inhibits formation of the 
perferryl form thus inhibiting peroxidase activity. Perferryl forms of 
hemoproteins have been implicated in the peroxidase activities of various 
hemoproteins (74, 113). 
Investigation of the metabolites formed when 17a-hydroperoxide 
derivatives of progesterone and pregnenolone interact with microsomal 
cytochrome P-450 preparations revealed two pathways of decomposition: 
1) a decomposition of the hydroperoxides by hepatic microsomal P-450 re-
sulting in a complex range of degradation products formed presumably by 
the interaction of free radical alkoxy or peroxy intermediates; formation 
of such reactive intermediates may account for the destruction of the hemo-
protein during the course of the reaction; 2) a catalytically-controlled 
reduction of the hydroperoxides by adrenocortical microsomal P-450 resulting 
in the formation of the corresponding 17a-hydroxy analogs together with a 
small amount of degraded c19-17-ketosteroids; this pathway of decomposition 
did not result in the destruction of the hemoprotein. 
Destruction of intracellular cytochrome P-450 by endogenous hydro-
peroxide may have undesired physiological consequences_ However, in the 
Scheme 2. Mechanism for microsomal TMPD-peroxidase activity 
- 137 
cell cytochrome P-450 may be protected by a variety of hydrogen donors 
such as NADPH, NADH, GSH, ascorbate, and vitamin E as well as by natural 
substrates (i.e. steroids, fatty acids) which compete with hydroperoxide 
for the "active site" on the hemoprotein. 
Several "activated oxygen" species such as hydroxyl radicals, 
superoxide ions, "oxenoid" species, steroidal alkoxy radicals, and epoxide 
species have been proposed as initial intermediates in the c y tochrome P-450-
catalyzed hydroxylation mechanism (44, 60-62, 114, 115). Hydroperoxide 
intermediates have been proposed in cholesterol side chain cleavage (67-70), 
steroid liS-hydroxylation (63), and in the hydroxylation of fluorene, 
tetralin, and other organic compounds (64-66) and these reactions apparently 
involve the participation of cytochrome P-450. Therefore, our finding that 
pregnene 17a-hydroperoxides are converted to their respective 17a-hydroxy 
analogs by adrenocortical microsomal P-450 preparations at comparable 
rates as found for certain hydroxylation reactions (C-21 hydroxylation of 
17a-hydroxy progesterone)could be of particular physiological significance. 
The formation of degraded cl9-17-ketosteroids from the 17a-hydro-
peroxides could also be of importance since this reaction could offer 
possibly a new biosynthetic route for the production of the androgen hor-
mones in steroidogenic tissue (116). In addition,our discovery that 
progesterone 17~-hydroperoxide can be converted to 17a, 21-dihydroxyprogest-
erone by adrenocortical microsomes in the presence of NADPH or NADH may 
open up a new pathway via which the corticosteroid hormones may be bio-
synthesized. 
It is evident that further studies on the role of steroid 
hydroperoxides as possible precursors of the steroid hormones in endocrine 
tissue are required. In particular, answers to the question of their 
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formation in active hydroxylase systems are called for and this particular 
area of research remains a challenge for the future. 
The microsomal NADPH-peroxidase electron transport system 
The role of various electron transport components in the 
microsomal NADPH-peroxidase enzyme system has been investigated. Several 
lines of evidence for the involvement of a similar electron transport 
system in NADPH-peroxidase activity and in substrate hydroxylation react-
ions in liver microsomes have been found: · 1) both activities require the 
participation of NADPH-cytochrome ~reductase and cytochrome P-450; 
2) both systems are inhibited by antibody to NADPH-cytochrome ~ reduct-
ase (31); 3) both reactions are stimulated by increasing ionic strength 
(32); 4) the activities are sensitive to inhibition by low concentrations 
of sulfhydryl reagents (33); 5) NADP+ causes an inhibition of both 
reactions; 6) the activities are inhibited to a similar extent by steroids; 
7) type I and type II substrates cause a marked inhibition; 8) reagents 
that convert cytochrome P-450 to cytochrome P-420 produce inactivation; 
9) both reactions are sensitive to inhibition by trypsin; 10) in vivo 
phenobarbital treatment causes a marked stimulation of both activities 
(117); 11) the K for NADPH in both systems is smaller than 3 ~M (28). 
m 
Gaylor and collaborators (57) investigated the binding of the 
modified type II ligand, cyanide, to the oxidized forms of cytochrome P-450 
in liver microsomes. Two binding constants for cyanide of 0.5 mM and 2.5 
mM were obtained suggesting the presence in liver microsomes of two 
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different species of oxidized P-450 (48, 57-59). Our results have 
demonstrated a 50% inhibition of NADPH-peroxidase activity by 2.2 mM 
cyanide suggesting the involvement in the reaction of the P-450 species 
that exhibits the lower affinity for cyanide. Gaylor and his group pro-
posed that the P-450 species exhibiting the higher affinity for cyanide 
is involved in the NADH-dependent sterol demethylation activity in liver 
microsomes, a reaction that is inhibited 50% by 0.5 mM cyanide. NADPH 
can also be used as an electron donor for sterol demethylation activity 
(58,59) and it will be interesting to see which of the two cyanide-
sensitive forms of P-450 is involved in the NADPH-dependent demethylation 
reaction. 
Inhibitor studies with antibody to NADPH-cytochrome c reductase 
revealed that changes in the activity of the flavoenzyme were paralleled 
by identical changes in NADPH-peroxidase activity. This finding coupled 
to the similarities in the response to various treatments of the £lava-
protein reductase activity and NADPH-peroxidase activity suggests that the 
reduction of cytochrome P-450 by NADPH-cytochrome ~ reductase may be the 
rate- determining step in the overall NADPH-peroxidase reaction (see scheme 4). 
Attempted reconstitution of the microsomal NADPH-peroxidase 
activity revealed that the enzyme system was labile to various solubilizat-
ion treatments. The cytochrome P-450 preparation when mixed with trypsin-
solubilized NADPH-cytochrome ~ reductase gave essentially the same 
reaction rate as the P-450 preparation mixed with detergent-solubilized 
flavoenzyme. Orrenius and collaborators (38) have suggested that solubil-
ization of NADPH-cytochrome c reductase from microsomes by trypsin is 
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responsible for the decreased rate of reduction of cytochrome P-450 and 
the subsequent inhibition of drug hydroxylation activity in trypsin-
treated microsomes. A lipase-solubilized flavoenzyme preparation of 
Williams and Kamin (29) was also shown to be ineffective in reducing 
partially purified cytochrome P-450 and this reconstituted system lacked 
the ability to catalyze thew-hydroxylation of fatty acids (52). It, 
therefore, appears that the low NADPH-peroxidase activity in our recon-
stituted system may be the result of the diminution in ability of solu-
bilized NADPH-cytochrome ~reductase to reduce cytochrome P-450. Micro-
somal lipid or phosphatidylcholine was found to enhance slightly the 
NADPH-peroxidase activity of the reconstituted system and it will be 
interesting to see what sort of phospholipid requirement exists for the 
enzyme system in intact liver microsomes. 
Incubation of cumene hydroperoxide with hepatic microsomal 
fractions fortified with NADPH results in the formation of the correspond-
ing hydroxy derivative as the major product. The conversion of hydroper-
oxides to alcohols by microsomal cytochrome P-450 appears to be an inherent 
characteristic of the hemoprotein. A scheme of NADPH-dependent microsomal 
electron transport accommodating the reduction of hydroperoxides to 
hydroxy derivatives is proposed in scheme 3. It is generally assumed that 
NADPH supplies reducing equivalents to cytochrome P-450 via the flavopro-
tein NADPH-cytochrome ~reductase (fp) either directly or through some 
unknown electron carrier "X" (32). The flavoprotein is also presumed to 
mediate the transfer of electrons from NADPH to cytochrome b 5 • In the 
presence of oxygen, reduced cytochrome P-450 catalyses the hydroxylation 
of various steroid and drug substrates (AH2 ) to yield hydroxylated product 
(AOH) and water. 
Scheme 3. Scheme of NADPH-~endent microsomal electron transport 
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Cytochrome P-450 can also act as a microsomal peroxidase 
(scheme 3) converting hydroperoxide (ROOH) to the corresponding alcohol 
(ROH), a reaction that does not require the presence of oxygen and is not 
sensitive to carbon monoxide. The insensitivity of NADPH-peroxidase 
activity to carbon monoxide is consistent with the observations of Chen 
and Lin (64) who found no apparent inhibition by CO of the NADPH-dependent 
conversion of tetralin hydroperoxide to tetralol. However, carbon monoxide 
was found to inhibit the hydroxylation of tetralin to tetralol, a reaction 
involving tetralin hydroperoxide as an intermediate (64). Therefore, it 
appears that in hydroxylation reactions involving hydroperoxides as inter-
mediates, the conversion of substrate to the transient hydroperoxide is 
sensitive to inhibition by carbon monoxide whereas the reduction of the 
hydroperoxide to the corresponding alcohol is insensitive to carbon monox-
ide. Several other P-450-dependent reactions have been found to be 
unaffected by carbon monoxide (27, 58, 59) and hence it appears that CO 
inhibition by itself is not always a reliable criterion for P-450 partici-
pation. 
The pathway presented in scheme 3 implies that hydroperoxides are 
capable of oxidizing reduced cytochrome P-450, a conclusion that has been 
verified by experiments carried out in this study. In this respect, 
hydroperoxides act in a similar manner to oxygen. The reduction of 
hydroperoxides to the corresponding hydroxy derivatives requires two re-
ducing equivalents as does the process of substrate hydroxylation whereas 
the reduction of ferric cytochrome P-450 by NADPH is a one-electron process 
(32). Hildebrandt and Estabrook (32) suggested that the second electron 
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in microsomal hydroxylation reactions is donated by reduced cytochrome b 5 
whereas Holtzmann and Carr (118) postulated a second reduced cytochrome 
P-450 molecule as being the electron donor. 
A tentative mechanism for microsomal NADPH-peroxidase activity is 
proposed inscheme 4. It is suggested that the first step in the reaction 
sequence is the reduction of ferric P-450 to ferrous P-450 by NADPH via 
NADPH-cytochrome ~ reductase. The second stage involves the interaction of 
hydroperoxide (ROOH) with ferrous P-450 to form ferryl P-450. Ferryl P-450 
can accept two electrons from NADPH to yield regenerated ferrous P-450. The 
conversion of ferrous P-450 to ferryl P-450 may proceed by one of two 
possible routes: 1) via an intermediate ferric P-450 state; or 2) as a 
single step two-electron oxidation analogous to the reaction of ferrous 
horseradish peroxidase with hydrogen peroxide (119). 
The microsomal NADH-peroxidase electron transport system 
The role of various electron transport components in the micro-
somal NADH-peroxidase enzyme system has been investigated. Evidence has 
been presented for the participation of NADH-cytochrome b 5 reductase and 
cytochrome P-450 as electron carriers in the reaction. 
A comparison of NADH-peroxidase activity and cytochrome P-450 
content in microsomal fractions from various tissues revealed that hepatic 
microsomes contained the highest amount of P-450 per mg protein and were the 
most active in catalyzing the NADH-peroxidase reaction. Microsomes from 
tissues which contained little or no cytochrome P-450 were either weakly 
active or completely inactive. However, the activity of bovine adreno-
cortical microsomes was very low as compared to liver microsomes, both 
rate-limiting 
P-4503+ NADPH 
2+ ROOH 4+ 
P-450 -=:::: >-- P-450 
NADPH 
Scheme 4. Mechanism for microsomal NADPH-peroxidase activity 
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fractions containing similar P-450 levels. These results are consistent 
with previous observations which showed a much lower TMPD-peroxidase and 
NADPH-peroxidase activity in adrenocortical microsomes as compared to 
liver microsomes, indicating that the two hemoproteins possess different 
peroxidase properties. 
The NADH-peroxidase activity in liver microsomes of phenobarbital-
induced rats showed a parallel increase to the rise in P-450 content when 
progesterone 17a-hydroperoxide was employed as substrate. In contrast, the 
specific activity of the enzyme system with cumene hydroperoxide as sub-
strate was enhanced several times more than could be accounted for by the 
rise in P-450 level. These results are consistent with previous observat-
ions which showed a drastic increase in TMPD-peroxidase activity and 
NADPH-peroxidase activity ~sing cumene hydroperoxide as substrate but only 
a moderate increase with progesterone 17a-hydroperoxide following pheno-
barbital treatment. 
Attempted reconstitution of the microsomal NADH-peroxidase 
activity revealed that the enzyme system was labile to various solubiliz-
ation treatments. The use in the reconstituted system of a cytochrome 
P-450 preparation plus detergent-solubilized NADH-cytochrome b 5 reductase 
gave essentially the same reaction rate as cytochrome P-450 plus 
lysosomal-solubilized flavoenzyme. The rate-limiting step in the overall 
reaction could not be determined with certainty but one would expect the 
reduction of ferric cytochrome P-450 to be the control point of the react-
ion, analogous to the situation occurring in the NADPH-peroxidase enzyme 
system. Therefore, the low NADH-peroxidase activity observed in the 
reconstituted system may reflect the diminution in ability of solubilized 
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NADH-cytochrome b 5 reductase to reduce cytochrome P-450. Addition to the 
reconstituted system of phosphatidylcholine-lysophosphatidylcholine 
micelles produced a slight increase in the reaction rate. Phospholipid 
requirements have been shown for several microsomal enzymes (52, 110) and 
it seems quite probable that the NADH-peroxidase enzyme system of intact 
liver microsomes also requires phospholipid for maximum catalytic activity. 
Incubation of cumene hydroperoxide with microsomal fractions 
fortified with NADH resulted in the formation of the corresponding hydroxy 
derivative as the major product. A scheme of NADH-dependent microsomal 
electron transport is proposed in scheme 5. It is suggested that NADH 
supplies reducing equivalents to cytochrome P-450 via the flavoenzyme NADH-
cytochrome ~ reductase (fp) either directly or through some unknown electron 
carrier. Reduced cytochrome P-450 then acts as a microsomal peroxidase con-
verting hydroperoxide (ROOH) to the corresponding alcohol (ROH), a reaction 
that does not require oxygen and is insensitive to inhibition by carbon mon-
oxide. This scheme implies that hydroperoxides are capable of oxidizing 
NADH-reduced cytochrome P-450, a conclusion supported by the results in this 
study. 
NADH-cytochrome b 5 reductase can also mediate the channelling of 
electrons from NADH to cytochrome b 5 . Reduced cytochrome b 5 then transfers 
reducing equivalents to a desaturase enzyme which converts stearyl coenzyme 
A to oleyl coenzyme A in the presence of oxygen (120-123). Reduced 
cytochrome b 5 can also channel electrons to externally added cytochrome c. 
Both the fatty acid desaturase enzyme system and NADH-cytochrome £ reductase 
require the presence of phospholipid (110, 120). The terminal desaturase 
appears to be a different enzyme from cytochrome P-450 (120-123). 
02 2 H20 ~1 
Cyt b5 -':!l-Qesaturase \ ~~t Stearyl 0 I eyl 
, Co A Co A 
Cyt c 
Scheme 5. Scheme of NADH-dependent microsomal electron transport 
.. 
,. ' 
A tentative mechanism for microsomal NADH-peroxidase activity 
is proposed in scheme 6. It is suggested that the first step in the 
reaction sequence is the reduction of ferric P-450 to ferrous P-450 by 
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NADH via NADH-cytochrome b 5 reductase. The second stage involves the 
interaction of hydroperoxide (ROOH) with ferrous P-450 to form ferryl P-450. 
Ferryl P-450 can accept two electrons from NADH to yield regenerated ferrous 
P-450. The conversion of ferrous P-450 to ferryl P-450 may proceed either 
via an intermediate ferric P-450 state or as a single step two-electron 
oxidation analogous to the reaction of ferrous horseradish peroxidase with 
hydrogen peroxide (119). 
Evidence for a similar electron transport system operating in 
NADH-peroxidase activity and in NADH-dependent sterol demethylation includes: 
1) utilization in both systems of NADH as the preferred electron donor; 
2) involvement of a cytochrome P-450 species that exhibits a high affinity 
for cyanide; 3) insensitivity of both reactions to inhibition by carbon mon-
oxide; 4) no decrease in both reaction rates after removal of cytochrome b 5 
by trypsin digestion (58, 59). In vivo phenobarbital treatment markedly 
enhanced the NADH-peroxidase reaction rate and it will be interesting to see 
what effect this treatment has on the sterol demethylation reaction. 
Conclusion 
A summary of the properties of the TMPD-peroxidase, NADPH-peroxidase, 
and NADH-peroxidase enzyme systems is presented in Table 35. Evidence 
suggesting the involvement of two distinct forms of cytochrome P-450 in the 
NADPH-peroxidase and NADH-peroxidase enzyme systems will now be discussed. 
First of all, the TMPD-peroxidase reaction is a measure of the 
P-4503+ NADH P-4502+ ROOH P-4504+ 
NADH 
Scheme 6. Mechanism for microsomal NADH-peroxidase activity 
TABLE 35 
SUMMARY OF THE PROPERTIES OF THE TMPD-PEROXIDASE, NADPH-PEROXIDASE, AND NADH-PEROXIDASE ENZYME SYSTEMSa 
Property 
b Stoichiometry 
Reaction rate c 
K for electron donor 
m 
K for cumene hydroperoxide 
m 
pH optimum 
d Induction by phenobarbital 
Concentration of cyanide required for 50% inhibition 
Concentration of ~-octylamine required for 50% inhibition 
Inhibition by N2 
Inhi bition by CO 
Involvement of NADPH-cytochrome .£ reductase 
Involvement of NADH-cytochrome ~5 reductase 
Involvement of cytochrome P-450 
Involvement of cytochrome ~ 
TMPD-Peroxidase NADPH-Peroxidase NADH-Peroxidase 
0.25 0.35 0.50 
73 28 37 
40 \.IM < 3 \.IM < 3 \.IM 
0.4 mM 0.6 mM 
6.5-7.7 8.2 7.7-7.8 
19-fold 7 .5-fold 10-fold 
0.8 mM 2.2 mH 0. 45 tru'1 
0.09 mM 0.24 mM 0.07 mM 
+ 
+ 
+ + + 
a To keep results consistent, the same batch of liver microsomes was used in obtaining the data for each of the 
b 
c 
d 
properties of the three enzyme systems. 
Stoichiometry expressed as moles electron donor oxidized/mole cumene hydroperoxide in presence of liver microsomes. 
Reaction rates expressed as nrnoles electron donor oxidized/min/mg protein/).lmole cumene hydroperoxide. 
One reducing equivalent is utilized when TMPD is oxidized to Wurster's blue whereas two reducing equivalents are 
used up when NAD(P)H is oxidized to NAD(P)+. 
Rats were injected intraperitoneally with sodium phenobarbital (50 mg/kg) twice daily for 5 days. 
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peroxidase activity of all the various forms of cytochrome P-450 in liver 
microsomes. On the other hand, the NADPH-peroxidase and NADH-peroxidase 
reaction measures only the peroxidase activity of NADPH-reducible and 
NADH-reducible cytochrome P-450, respectively. The TMPD-peroxidase, 
NADPH-peroxidase, and NADH-peroxidase reactions were enhanced 19-fold, 
7.5-fold, and 10-fold, respectively, following phenobarbital treatment. 
Combining the increases in the latter two activities gives a total increase 
of 17.5-fold, a value which is similar to the 19-fold stimulation observed 
for the TMPD-peroxidase reaction. 
Secondly, the P-450 species involved in the NADH-peroxidase 
enzyme system has a high affinity for cyanide and n-octylamine, the P-450 
species which functions in the NADPH-peroxidase reaction exhibits a low 
affinity for cyanide and ]l-octylamine, and the cytochrome P-450 species 
which participate in the TMPD-peroxidase reaction have an intermediate 
affinity for the inhibitory agents. These results are suggestive of the 
presence of two different forms of cytochrome P-450 in liver microsomes, 
one form functioning in NADPH-dependent activities and the other playing 
a role in NADH-supported reactions. 
Challenges for the future include isolation and purification of 
the various forms of cytochrome P-450, determination of their electron donor 
and substrate specificities, and reconstitution of functional NADPH- and 
NADH-supported cytochrome P-450-dependent enzyme activities. 
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